Advertisement

Klinik der Kardiomyopathien

  • L. Görnandt
  • P. Bubenheimer
  • H. Reindell
  • A. Weisswange

Zusammenfassung

Der nosologische Begriff Kardiomyopathie wurde erstmals von Bridgen (1975) im heutigen Sinne angewandt Er bezeichnete damit Myokarderkran-kungen, die nicht durch eine Erkrankung der Koronararterien bedingt waren. Mattingly (1958, 1961, 1970) faßte ähnlich verlaufender aber auf eine Vielzahl ätiologischer Faktoren zurückführende Erkrankungen des Herzmuskels unter dem Begriff der primären myokardialen Erkrankungen zusammen. Nach der heute einheitlich angwandten Definition werden mit dem Begriff Kardiomyopathie alle Erkrankungen des Herzmuskels eprfaßt. die weder durch eine Koronarerkrankung noch durch eine Hypertonie im großen und kleinem Kreislauf noch durch ein Vitium des Herzens hervorgerufen werden (Grosse-Brockhoff 1971; Kühler et al 1972, 1973; Loogen u. Kuhn 1975; Kuhn et al. 1977).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abbasi AS, McAlpin RN, Eber LM, Pearce ML (1972 a) Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 46:897PubMedGoogle Scholar
  2. Abbasi AS, Chahine RA, McAlpin RN, Kattus AA (1972b) Echocardiographic study of the left ventricular function in primary congestive cardiomyopathy. Chest 62:357CrossRefGoogle Scholar
  3. Abelmann WH (1971) Virus and the heart. Circulation: 950Google Scholar
  4. Abelmann WH (1984) Heavy drinking and the cardiovascular system. J cardiovasc Med 9:695Google Scholar
  5. Adelman AG, Shah PM, Gramiak R et al (1970) Long-term propranolol therapy in muscular subaortic stenosis. Brit Heart J 32:804PubMedCrossRefGoogle Scholar
  6. Adelman AG, Wigle ED, Ranganathan N, Webb GD, Kidd BS, Bigelow WG, Silver MD (1972) The clinical course in muscular subaortic stenosis: A retrospective and prospective study of 60 hemodynamically proved cases. Ann intern Med 77:515PubMedGoogle Scholar
  7. Alexander CS (1966) Idiopathic heart disease. I. Analysis of 100 cases with special reference to chronic alcoholism. Amer J Med 41:213PubMedCrossRefGoogle Scholar
  8. Alexander CS (1968) The concept of alcoholic myocardiopathy. Med clin N Amer 52:1183PubMedGoogle Scholar
  9. Alexander CS (1972) Cobalt-beer cardiomyopathy. A clinical pathologic study of twenty-eight cases. Amer J Med 53Google Scholar
  10. Alexander CS (1975) Alcoholic cardiomyopathy. Postgrad Med J 58:127Google Scholar
  11. Anderson JL, Lutz JR, Gilbert EM et al (1985) A randomized trial of low dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 55:471PubMedCrossRefGoogle Scholar
  12. Anschütz F (1975) Virus-Myokarditis. Diagnostik 8:175Google Scholar
  13. Anschütz F, Mende E (1968) Die Karditis des akuten rheumatischen Fiebers im Jugend- und Erwachsenenalter. Dtsch med Wschr 93:7PubMedCrossRefGoogle Scholar
  14. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EGJ, Schoen FJ (1987) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3PubMedGoogle Scholar
  15. Askanas A, Udoshi M, Sadjadi SA (1980) The heart in chronic alcoholism: a noninvasive study. Amer Heart J 99:9PubMedCrossRefGoogle Scholar
  16. Ayuthya PSN, Jayavasu J, Pongpanich B (1974) Coxsackie group B virus and primary myocardial disease in infants and children. Amer Heart J 88:311CrossRefGoogle Scholar
  17. Bader HS (1963) Contractile tension in the myocardium. Amer Heart J 66:432CrossRefGoogle Scholar
  18. Barr PA, Celermajer JM, Bowdler JD et al (1973) Idiopathic hypertrophic obstructive cardiomyopathy causing severe right ventricular outflow tract obstruction in infancy. Brit Heart J 35:1109PubMedCrossRefGoogle Scholar
  19. Bashour FA, McConnel X, Skinner T, Hansen W (1968) Myocardial sarcoidosis. Dis Chest 53:413PubMedCrossRefGoogle Scholar
  20. Baudet M, Rigaud M, Rocha P, Bardet J, Bourdarias JP (1979) Reversibility of alcoholic cardiomyopathy with abstention from alcohol. Cardiology 64:317PubMedCrossRefGoogle Scholar
  21. Behrend H et al (1969) Die Klinik und Diagnostik der Sarkoidose. Internist 10:293PubMedGoogle Scholar
  22. Bemiller CE, Pepine CJ, Rogers AK (1973) Long-term observations in patients with angina and normal coronary arteriograms. Circulation 47:36PubMedGoogle Scholar
  23. Bengtsson E (1968) Myocarditis and cardiomyopathy. Cardiologia, Basel 52:97PubMedCrossRefGoogle Scholar
  24. Bengtsson E (1972) Acute myocarditis and its consequences in Sweden. Postgrad Med J 48:754PubMedCrossRefGoogle Scholar
  25. Bengtsson E, Lamberger B (1966) Five-year follow-up study of cases suggestive of acute myocarditis. Amer Heart J 72:751PubMedCrossRefGoogle Scholar
  26. ten Berg JM, Suttorp M J, Knaepen PJ et al (1994) Hypertrophic obstructive cardiomyopathy: initial results and long-term follow-up after Morrow septal myectomy. Circulation 90:1781PubMedGoogle Scholar
  27. Bernheim PL (1910) De Pastolie veineuse dans l’hypertrophie du cœur gauche, par sténose concomitante du ventricle droit. Rev méd 30:785Google Scholar
  28. Bertrand M (1982) Myocardial function in myocardial disease. In: Roskamm H, Csapo G (eds) Disorders of cardiac function. Marcel Dekker, New YorkGoogle Scholar
  29. Beuren A J, Koncz J, Kochsiek K (1961) Funktionelle Subaorten-stenose als Folge einer „Kardiomyopathie“ unbekannter Ursache. Z Kreisl-Forsch 50:1162Google Scholar
  30. Beyer J, Klinner W (1975) Die IHSS als chirurgisch bedeutsame primäre Kardiomyopathie. Z Kardiol Suppl 2:21Google Scholar
  31. Bigelow WG, Trimble AS, Auger P et al (1966) The ven-triculomyotomy operation for muscular subaortic stenosis: A reappraisal. J thorac cardiovasc Surg 52:514PubMedGoogle Scholar
  32. Bjòrk L (1977) Die röntgenologische Symptomatologie der Kardiomyopathien. Röntgen-Bl 30:432Google Scholar
  33. Bland EF, Jones TD (1951) Rheumatic fever and rheumatic heart disease. Circulation 4:386Google Scholar
  34. Bliss HA, Moffat JE, Gautt CL (1967) Effects of chronic oral Propranolol therapy in idiopathic hypertrophic subaortic stenosis. Circulation, Suppl II, 35/36:72Google Scholar
  35. Blömer H, Delius W (1975) Prognostische Beurteilung von Patienten mit primärer Kardiomyopathie. Internist 16:548PubMedGoogle Scholar
  36. Bollinger O von (1884) Über die Häufigkeit und Ursachen der idiopathischen Herzhypertrophie in München. Dtsch med Wschr 10:180CrossRefGoogle Scholar
  37. Bolte HD (1975 a) Diagnostische Wertigkeit des indirekten Immunfluoreszenztests zum Nachweis humoraler Antikörper gegen Myokard. Internist 16:180PubMedGoogle Scholar
  38. Bolte HD (1975 b) Die rheumatische Karditis. Internist 16:501PubMedGoogle Scholar
  39. Bolte HD (1975 c) Entzündliche Herzerkrankungen und Kardiomyopathien. In: Riecker G (ed) Klinische Kardiologie. Springer, Berlin Heidelberg New York, S 53Google Scholar
  40. Bolte HD, Grothey K (1977) Cardiomyopathies, related to immunological processes. In: Riecker G, Weber A, Goodwin JF (eds) Springer, Berlin Heidelberg New York, S 266Google Scholar
  41. Bolte HD, Schultheiss P, Cyran J, Goss G (1980) Binding of Immunglobulins in the myocardium (biopsies) in cardiomyopathies. In: Bolte HD (ed) Myocardiobiopsies. Springer, Berlin Heidelberg New York, S 85Google Scholar
  42. Bolte HD, Fischer S, Ludwig B (1982) Immunologische Untersuchungsbefunde bei dilativen Kardiomyopathien. Z Kardiol 71:517PubMedGoogle Scholar
  43. Bonfiglio TH, Atwater EC (1969) Heart disease in patients with seropositive rheumatoid arthritis. Arch intern Med 124:714PubMedCrossRefGoogle Scholar
  44. Braunwald E, Ebert PA (1962) Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Amer J Cardiol 10:489PubMedCrossRefGoogle Scholar
  45. Braunwald E, Aygen MM (1963) Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood-flow. Amer J Med 35:7PubMedCrossRefGoogle Scholar
  46. Braunwald E, Brockenbrough EC, Morrow AG (1962) Hypertrophic subaortic stenosis — a broadened concept (editorial). Circulation 26:161PubMedGoogle Scholar
  47. Braunwald E, Brockenbrough EC, Frye RL (1962) Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis. Circulation 26:166PubMedGoogle Scholar
  48. Braunwald E, Marrow AG, Cronell WF, Aygen MM, Hilbish TF (1960) Idiopathic hypertrophic subaortic stenosis: Clinical, hemodynamic and angiographic manifestations. Amer J Med 29:924CrossRefGoogle Scholar
  49. Braunwald E, Lambrew CT, Rockoff SD, Ross J Morrow AG (1964 a) Idiopathic hypertrophic subaortic stenosis. A description of the disease based upon analysis of 64 patients. Circulation Suppl 30/IV:3Google Scholar
  50. Braunwald E, Oldham HN jr, Linhart JW, Mason DT, Fort III L, (1964 b) The circulatory response of patients with idiopathic hypertrophic subaortic stenosis to nitroglycerin and to the Valsalva maneuver. Circulation 29:422PubMedGoogle Scholar
  51. Bridgen W (1975) Uncommon myocardial diseases, the non coronary cardiomyopathies. Lancet 11:1179 u. 1243Google Scholar
  52. Brock R (1957) Functional obstruction of the left ventricle. Guy’s Hosp Rep 108:221Google Scholar
  53. Brockenbrough EC, Braunwald E, Morrow AG (1961) A hemodynamic technique for the detection of hypertrophic subaortic stenosis. Circulation 23:189Google Scholar
  54. Bryg RJ, Pearson AC, Williams GA, Labovitz A J (1987) Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Amer J Cardiol 59:925PubMedCrossRefGoogle Scholar
  55. Bubenheimer P (1982) Echokardiogramm bei hypertrophischer Myokardiopathie. In: Roskamm H, Reindell H (eds) Herzkrankheiten, 2. Aufl. Springer, Berlin Heidelberg New York, S 1117Google Scholar
  56. Bubenheimer P (1982) Echokardiogramm bei congestiver und dilatativer Kardiomyopathie. In: Roskamm H, Reindell H (eds) Herzkrankheiten, 2. Aufl. Springer, Berlin Heidelberg New York, S 1128Google Scholar
  57. Bubenheimer P, Samek L, Schmeisser HJ, Roskamm H (1978) Echocardiographic evaluation of left ventricular function during exercise in untrained young men and athletes. In: Lubich T, Venerando A (eds) Sports Cardiology. Aulo Gaggi, Bologna, S 787Google Scholar
  58. Buhner R, Drings P, Rossner E A (1977) Klinisch pathologische Aspekte der Adriamycin-induzierten Cardiomyopathie. Verh dtsch Ges inn Med 83:1235PubMedGoogle Scholar
  59. Bulkley BH, Fortuin NH (1976) Systolic anterior motion of the mitral valve without asymmetric septal hypertrophy. Chest 69:694PubMedCrossRefGoogle Scholar
  60. Bulkey BH, Weisfeldt ML, Hutchins GM (1977) Asymmetric septal hypertrophy and myocardial fiber disarray — features of normal, developing and malformed hearts. Circulation 56:292Google Scholar
  61. Burch GE (1955) Theoretic considerations of the time course of pressure developed and volume ejected by the normal and dilated left ventricle during systole. Amer Heart J 50:352PubMedCrossRefGoogle Scholar
  62. Burch GE, DePasquale NP (1969) Alcoholic cardiomyopathy. Amer J Cardiol 23:723PubMedCrossRefGoogle Scholar
  63. Burch GE, Giles TD (1972) The role of viruses in the production of heart disease. Amer J Cardiol 29:231PubMedCrossRefGoogle Scholar
  64. Burch GE, Walsh JJ, Black WC (1963) Value of prolonged bed rest in management of cardiomegaly. J Amer med Ass 183:83CrossRefGoogle Scholar
  65. Burch GE, DePasquale NP, Cronvich JA (1965 a) Influence of ventricular size on the relationship between contractile and manifest tension. Amer Heart J 69:624PubMedCrossRefGoogle Scholar
  66. Burch GE, Walsh JJ, Ferrans VJ, Hibbs R (1965 b) Prolonged bed rest in the treatment of the dilated heart. Circulation 32:852PubMedGoogle Scholar
  67. Burch GE, Shih-Chien Sein, K-Ch Chu, Sohal RS, Colcolough H J (1968) Interstitial and Coxsackie B myocarditis in infants and children. A comparative study of 50 autopsied hearts. J Amer med Ass 203:55CrossRefGoogle Scholar
  68. Burch GE, Harb JM, Colcolough HL, Tsui CY (1971) The effect of prolonged consumption of beer, wine and ethanol on the myocardium of the mouse. Johns Hopkins med J 129:130PubMedGoogle Scholar
  69. Burch GE, Giles TD, Tsui CY (1972) Postpartal cardiomyopathy. Cardiovasc Clin 4:720Google Scholar
  70. Burkart F, Jenzer HR (1968) Der Arbeitsversuch zur Beurteilung von Kardiomyopathien. Schweiz med Wschr 98:1241Google Scholar
  71. Cambridge G, MacArthur CGC, Waterson AP, Goodwin JF, Oakley CM (1979) Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Brit Heart J 41:692PubMedCrossRefGoogle Scholar
  72. Canedo MI, Frank MJ, Abdulla AM (1980) Rhythm disturbances in hypertrophic cardiomyopathy: Prevalence, relation to symptoms and management. Amer J Cardiol 45:848PubMedCrossRefGoogle Scholar
  73. Cetta F, Michels VV (1995) The natural history and spectrum of idiopathic dilated cardiomyopathy, including HIV and peripartum cardiomyopathy. Curr Opin Cardiol 10: 332PubMedCrossRefGoogle Scholar
  74. Chandraratna PA, Nimalasuriya A, Reid CL et al (1983) Left ventricular asynergy in acute myocarditis. Stimulation of acute myocardial infarction. J Am Med Ass 250:1428CrossRefGoogle Scholar
  75. Carr D, Friesen HG (1976) Growth hormone and insulin binding to human, liver. J clin Endocrinol Metab 42:484PubMedCrossRefGoogle Scholar
  76. Cherian G, Brockington JF, Shah PM, Oakley CM, Goodwin JF (1966) Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Amer J Cardiol 18:481CrossRefGoogle Scholar
  77. Cherian G, Brockington JF, Shah PM, Oakley CM, Goodwin JF (1967) Beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathy. Amer Heart J 73:140PubMedCrossRefGoogle Scholar
  78. Chiaramida SA, Goldman MA, Zema MJ, Pizzarello RA, Goldberg HM (1980) Real-time cross-sectional echocardiographic diagnosis of infiltrative cardiomyopathy due to amyloid. J clin Ultrasound 8:58PubMedCrossRefGoogle Scholar
  79. Child JS, Krivokapich J, Abbasi AS (1979) Increased right ventricular wall thickness on echocardiography in amyloid infiltrative cardiomyopathy. Amer J Cardiol 44:1391PubMedCrossRefGoogle Scholar
  80. Chung KJ, Manning JA, Gramiak R (1974) Echocardiography in coexisting hypertrophic subaortic stenosis and fixed left ventricular outflow obstruction. Circulation 49:673PubMedGoogle Scholar
  81. Clark CE, Henry WL, Epstein SE (1973) Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. New Engl J Med 289:709PubMedCrossRefGoogle Scholar
  82. Cohen LS, Braunwald E (1967) Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation 35:847PubMedGoogle Scholar
  83. Cohen J, Effat H, Goodwin JF, Oakley CM, Steiner RE (1964) Hypertrophic obstructive cardiomyopathy. Brit Heart J 26:16PubMedCrossRefGoogle Scholar
  84. Cohen MV, Cooperman LB, Rosenblum R (1975) Regional myocardial function in idiopathic hypertrophic subaortig stenosis — an echocardiographic study. Circulation 52:842PubMedGoogle Scholar
  85. Come PC, Bulkley BH, Goodman ZD, Hutchins GM, Pitt B, Fortuin NJ (1977) Hypercontractile cardiac states stimulating hypertrophic cardiomyopathy. Circulation 55:901PubMedGoogle Scholar
  86. Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl J Med 316:1429CrossRefGoogle Scholar
  87. Cooley DA, Leachman RD, Hallman GL et al (1971) Idiopathic hypertrophic subaortic stenosis: Surgical treatment including mitral valve replacement. Arch Surg 103:606PubMedCrossRefGoogle Scholar
  88. Corya BC, Rasmussen S, Feigenbaum H, Knöbel SB, Black MJ (1977) Systolic thickening and thinning of the septum and posterior wall in patients with coronary artery disease, congestive cardiomyopathy and atrial septal defect. Circulation 55:109PubMedGoogle Scholar
  89. Cote M, Davignon A, Elias G et al (1976) Hemodynamic findings in Friedreich’s ataxia. Can J neurol Sci 3:333PubMedGoogle Scholar
  90. Criley JM, Lewis KB, White RI jr. et al (1965) Pressure gradients without obstruction: A new concept of “hypertrophic subaortic stenosis”. Circulation 32:881PubMedGoogle Scholar
  91. Criley JM, Blaufuss AH, Abbasi AS (1975) Nonobstructive IHSS. Circulation 52:963PubMedGoogle Scholar
  92. Darsee JR, Nutter DO, Hopkins LC, Heymsfield SB (1979) Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation 59:492PubMedGoogle Scholar
  93. D’Cruz IA, Lalmalani GG, Sambasivan V, Cohen HC, Glick G (1979) The superiority of mitral E point-ventricular septum separation to other echocardiographic indicators of left ventricular performance. Clin Cardiol 2:140PubMedGoogle Scholar
  94. Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331:1564PubMedCrossRefGoogle Scholar
  95. Delius W, Sebening H, Oversohl K, Weghmann N, Wirtzfeld A (1975) Verlaufsbeobachtungen bei Patienten mit kongestiver Kardiomyopathie. Z Kardiol Suppl 2:19Google Scholar
  96. Denny FW, Ayoub EM, Dillon HC jr et al (1971) Prevention of rheumatic fever: A statement by the Rheumatic Fever Committee of the Council on Rheumatic Fever and Congenital Heart Disease of the American Heart Association. Circulation 43:983Google Scholar
  97. Dickhuth H-H, Simon G, Kindermann V, Wilberg A, Keul J (1979) Echokardiographische Untersuchungen bei Sportlern verschiedener Sportarten und Untrainierten. Z Kardiol 68:49Google Scholar
  98. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796PubMedCrossRefGoogle Scholar
  99. Dinsmore RE, Sanders Ch A, Harthorne JW (1966) Mitral regurgitation in idiopathic hypertrophic subaortic stenosis. New Engl J Med 275:1225PubMedCrossRefGoogle Scholar
  100. Doerr W (1967) Entzündliche Erkrankungen des Myokard. Verh dtsch Ges Path 51:67Google Scholar
  101. Doerr W (1971) Morphologie der Myokarditis. Verh dtsch Ges inn Med 77:301PubMedGoogle Scholar
  102. Doerr W (1974) Organpathologie, Bd I. Thieme, StuttgartGoogle Scholar
  103. Doerr W, Rossner JA, Dittgen R, Rieger P, Derks H, Berg G (1976) Cardiomyopathie, idiopathische und erworbene Formen und Ursachen. Sitzungsber Heidelb Akad Wiss, math-naturw Kl, 5. Abh, S 477. Springer, Berlin Heidelberg New YorkGoogle Scholar
  104. Domenicucci S, Lazzeroni E, Roelandt J, Ten Cate FJ, Vletter WB, Arntzenius AC, Das SK (1985) Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study. Brit Heart J 53:405PubMedCrossRefGoogle Scholar
  105. Doval HC, Nul DR, Grancelli HO et al (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insufficiencia Cardiaca en Argentina (GESICA). Lancet 344:493PubMedCrossRefGoogle Scholar
  106. Drexler H (1995) Changes in peripheral circulation in heart failure. Current Opinion in Cardiology 10:268PubMedCrossRefGoogle Scholar
  107. Dye CL, Rosenbaum D, Lowe JC, Behnko RH, Genovese PP (1963) Primary myocardial disease. Part I. Clinical features. Ann intern Med 58:426Google Scholar
  108. Edington GM, Hutt MSR (1968) Idiopathic cardiomegaly: General and pathology. Cardiologia (Basel) 52:33Google Scholar
  109. Eggebrecht RF, Kleiger RE (1977) Echocardiographic patterns in scleroderma. Chest 71:47PubMedCrossRefGoogle Scholar
  110. Engelmeier RS, O’Connell JB, Walsh R et al (1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial. Circulation 72:526CrossRefGoogle Scholar
  111. Epstein SE, Rosing DR (1981) Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 64:437PubMedCrossRefGoogle Scholar
  112. Epstein SE, Henry WL, Clark CE, Roberts WC, Maron BJ, Ferrans VJ, Redwood DR, Morrow AG (1974) Asymmetric septal hypertrophy. Ann intern Med 81:650Google Scholar
  113. Falcone DM, Moore D, Lambert EC (1967) Idiopathic hypertrophic cardiomyopathy involving the right ventricle. Amer J Cardiol 19:735PubMedCrossRefGoogle Scholar
  114. Fananapazir L, Cannon RO, Tripodi D, Panza JA (1992) Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy refractory to verapamil and β-adrenergic blocker therapy. Circ 85:2149Google Scholar
  115. Fassbender HG (1963) Nosologische Typen des rheumatischen Granuloms und ihre biologische Bedeutung. Z Pathol, Frankfurt 72:586Google Scholar
  116. Fassbender HG (1969) Zwei unterschiedliche Formen pathologisch-anatomischer Gewebsprozesse bei primär chronischer Polyarthritis. Verh dtsch Ges Rheumatol 1:222PubMedGoogle Scholar
  117. Fassbender HG (1970) Spezifische und unspezifische Struktur entzündlich-rheumatischer Erkrankungen. Med Klin 2152Google Scholar
  118. Feigenbaum H (1985) Echokardiographie. In: Autenriet G (ed) Echokardiographie, 2. Aufl. Perimed, ErlangenGoogle Scholar
  119. Feizi Ö, Emanuel R (1975) Echocardiographic spectrum of hypertrophic cardiomyopathy. Brit Heart J 37:1286PubMedCrossRefGoogle Scholar
  120. Feizi Ö, Farrer-Brown G, Emanuel R (1978) Familial study of hypertrophic cardiomyopathy and congenital aortic valve disease. Amer J Cardiol 41:956PubMedCrossRefGoogle Scholar
  121. Ferrans VJ, Hibbs R, Birch G et al (1965) Myocardial degeneration in cardiac sarcoidosis. Amer Heart J 69:159PubMedCrossRefGoogle Scholar
  122. Ferrans VJ, Morrow AG, Roberts WC (1972) Myocardial ultra-structure in idiopathic hypertrophic subaortic stenosis. Circulation 45:769PubMedGoogle Scholar
  123. Ferrans VJ, Massumi RA, Shugoll EJ, Ali N, Roberts WC (1974) Ultrastructural studies on myocardial biopsies in 45 patients with obstructive or congestive cardiomyopathy. In: Bajusz E, Rona G (eds) Cardiomyopathies, S 231. Urban & Schwarzenberg, MünchenGoogle Scholar
  124. Fiddler GI, Tajik AJ, Weidman WH et al (1978) Idiopathic hypertrophic subaortic stenosis in the young. Amer J Cardiol 42:793PubMedCrossRefGoogle Scholar
  125. Fiedler A (1899) Über akute interstitielle Myokarditis. Vortr Ges f Naturu. Heilk, Dresden 9.10.1897, ausführlich in: Festschr Feier d fünfzigj Bestehens d Stadtkrankenhauses Dresden-Friedrichstadt. W Baensch, DresdenGoogle Scholar
  126. Fishbein MC, Blaufuss AH, Zamboli L, Briley JM, Laks MM (1975) Myocardial arterioles in “Syndrome x”. Circulation Suppl 2:90Google Scholar
  127. Flamm MD, Harrison DC, Hancock EW (1968) Muscular subaortic stenosis: Prevention of outflow obstruction with propranolol. Circulation 38:846PubMedGoogle Scholar
  128. Fleckenstein A (1967) Stoffwechselprobleme bei der Myo-kard-Insuffizienz. Verh dtsch Ges Pathol 51:15PubMedGoogle Scholar
  129. Fleming H (1973) Myocardial sarcoidosis. Lancet 1:106PubMedCrossRefGoogle Scholar
  130. Fowler NO (1964) Classification and differential diagnosis of the myocardiopathies. Progr cardiovasc Dis 7:1CrossRefGoogle Scholar
  131. Fowler NO (1971a) Differential diagnosis of cardiomyopathies. Progr cardiovasc Dis 14:113CrossRefGoogle Scholar
  132. Fowler NO (1971b) Autoimmune heart disease. Circulation 44:159PubMedGoogle Scholar
  133. Fowler NO, Gueron M (1965) Primary myocardial disease. Circulation 32:830PubMedGoogle Scholar
  134. Frank MJ, Abdulla AM, Canedo MI et al (1978) Long-term medical management of hypertrophic obstructive cardiomyopathy. Amer J Cardiol 42:993PubMedCrossRefGoogle Scholar
  135. Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37:759PubMedGoogle Scholar
  136. Frenzel H, Kasper M, Kuhn H, Lösse B, Reifschneider G, Hort W (1985) Licht- und elektronenmikroskopische Befunde in Früh- und Spätstadien der Herzinsuffizienz. Untersuchungen an Endomyokardbiopsien von Patienten mit latenter (LCM) und dilatativer (DCM) Kardiomyopathie. Z Kardiol 74:135PubMedGoogle Scholar
  137. Freundlich IM, McMurray JT, Lehman JS (1967) Idiopathic hypertrophic subaortic stenosis. Amer J Roentgenol 100:284PubMedGoogle Scholar
  138. Frey N (1975) Häufung von Coxsackie-Virus-B-Myokarditiden im Ruhrgebiet 1973/74. Med Welt 26:1275PubMedGoogle Scholar
  139. Frye RL, Kincaid OW, Swan HJC et al (1965) Results of surgical treatment of patients with diffuse subvalvular aortic stenosis. Circulation 32:52PubMedGoogle Scholar
  140. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL (1981) The natural history of idiopathic dilated cardiomyopathy. Amer J Cardiol 47:525PubMedCrossRefGoogle Scholar
  141. Ghosh P et al (1972) Myocardial sarcoidosis. Brit Heart J 34:769PubMedCrossRefGoogle Scholar
  142. Gilbert EM, SDi Lenarda A, O’Connell JB (1993) Prognosis and management, dilated cardiomyopathy. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 46–63CrossRefGoogle Scholar
  143. Giuliani ER, Tajik AJ, Frye RL et al (1972) Idiopathic hypertrophic subaortic stenosis (IHSS) and associated coronary artery disease (abstract). Circulation 46 (suppl 2):156Google Scholar
  144. Goldman JH, McKenna WJ (1995) Immunopathogenesis of dilated cardiomyopathies. Curr Opin Cardiol 10:306PubMedCrossRefGoogle Scholar
  145. Goodman DJ, Harrison DC, Popp RL (1974) Echocardio-graphic features of primary pulmonary hypertension. Amer J Cardiol 33:438PubMedCrossRefGoogle Scholar
  146. Goodwin JF (1970) Congestive and hypertrophic cardiomyopathies. Lancet 1:731CrossRefGoogle Scholar
  147. Goodwin JF (1974) Prospects and predictions for the cardiomyopathies. Circulation 50:210PubMedGoogle Scholar
  148. Goodwin JF (1978) Cardiomyopathy classification, part 2. In: Hurst JW (ed) The Heart. McCraw-Hill, New York, S 1556Google Scholar
  149. Goodwin JF (1980) Hypertrophic cardiomyopathy: A disease in search of its own identity. Amer J Cardiol 45:177PubMedCrossRefGoogle Scholar
  150. Goodwin JF, Oakley CM (1972) The cardiomyopathies. Brit Heart J 34:545PubMedCrossRefGoogle Scholar
  151. Goodwin JF, Gordon H, Hollman A, Bishop MB (1961) Clinical aspects of cardiomyopathy. Brit med J 1:69PubMedCrossRefGoogle Scholar
  152. Goodwin JF (1993 a) Clinical aspects. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 147–164CrossRefGoogle Scholar
  153. Goodwin JF (1993 b) Clinical aspects. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 67–84CrossRefGoogle Scholar
  154. Gore I, Saphir O (1967) Myocarditis a classification of 1402 cases. Amer Heart J 34:827CrossRefGoogle Scholar
  155. Gorlin RJ, Anderson RC, Blaw M (1969) Multiple lentigines syndrome: complex comprising multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia, retardation of growth, sensorineural deafness, and autosomal dominant hereditary pattern. Amer J Dis Child 117:652PubMedGoogle Scholar
  156. Gramiak R, Shah PM, Kramer DH (1969) Ultrasound cardiography: Contrast studies in anatomy and function. Radiology 92:939PubMedGoogle Scholar
  157. Gras D, De Place C, Lequerc C et al (1994) Key importance to individually optimize atrioventricular synchrony in obstructive hypertrophic cardiomyopathy treated by DDD-pacing. Eur Heart J 15 (Suppl):522Google Scholar
  158. Gräser I (1967) Rheumatische Erkrankungen im Kindesalter. Ergebn inn Med Kinderheilk 25:102PubMedGoogle Scholar
  159. Grist NR, Bell EJ (1969) Coxsackie viruses and the heart. Amer Heart J 77:295PubMedCrossRefGoogle Scholar
  160. Grodzinski E, Kreutz F, Blümchen G, Borer JS (1983) Über das Verhalten der Ruhe- und Belastungs-Auswurffraktion (EF) bei Herzinfarktpatienten vor und nach vierwöchigem Training. Vergleich zu einer Kontrollgruppe. Z Kardiol 72:105PubMedGoogle Scholar
  161. Grodzinski E, Fentrop T, Scharf-Bornhofen E, Keller T, Bierck G, Borer JS, Schoop W, Blümchen G (1985) Bedeutung der Auswurffraktion (EF) in Ruhe und bei Belastung mit Hilfe der Radionuklidventrikulographie für die Prognose von Herzinfarktpatienten. Vergleich mit anderen Untersuchungsmethoden. Z Kardiol 74:525PubMedGoogle Scholar
  162. Grosse-Brockhoff F (1971) Zur Klassifizierung, Ätiologie und Pathogenese der Myokardiopathien. Dtsch med Wschr 96:659PubMedCrossRefGoogle Scholar
  163. Gulotta SJ, Hamby RI, Aronson AL et al (1972) Coexistent idiopathic hypertrophic subaortic stenosis and coronary arterial disease. Circulation 46:890PubMedGoogle Scholar
  164. Hagemann GJ (1976) Elektrokardiogramm, Herzgröße und Hämodynamik in Ruhe und unter Belastung bei primärer chronischer Kardiomyopathie. Habil, Freiburg/BreisgauGoogle Scholar
  165. Hagemann GJ (1979) Sarkoidose von Herz und Gefäßen. In: Wurm K (ed) Sarkoidose. Thieme, Stuttgart New YorkGoogle Scholar
  166. Hagemann GJ (1983) Herz und Gefäße. In: Wurm K (ed) Sarkoidose. Thieme, Stuttgart New York, S 136Google Scholar
  167. Hagemann GJ, Wurm K (1978) Electrocardiographic findings in sarcoidosis. 7. Congress in sarcoidosis. CardGoogle Scholar
  168. Hagemann GJ, Reindell H, Schareck W, Wink K, Barmeyer J (1976) Herzvolumen und Hämodynamik (Ruhe, Belastung) bei erworbenen Myokardiopathien. Verh dtsch Ges inn Med 82:1040PubMedGoogle Scholar
  169. Hamby RI, Apiado OU, Khan AH (1968) Hemodynamics and left ventricular pressure-volume changes in primary myocardial disease. Circulation 37/38 (Suppl VI):93Google Scholar
  170. Hamby RI, Catangay P, Apiado OU, Khan AH (1970) Primary myocardial disease. Clinical hemodynamic and angiographic correlates in fifty patients. Amer J Cardiol 25:625PubMedCrossRefGoogle Scholar
  171. Hanrath P, Schweizer P, Bleifeld W, Effert S (1975) Differentialdiagnose kongestiver und hypertropher Myokardiopathien mittels Echokardiographie. Z Kardiol Suppl 2:12Google Scholar
  172. Hanrath P, von Essen R, Bleifeld W, Effert S (1976) Idiopathisch hypertrophe subaortale Stenose bei valvulärer Aortenklappenerkrankung — Diagnostik mittels Echokardiographie. Z Kardiol 65:964PubMedGoogle Scholar
  173. Hanrath P, Schweizer P, Bleifeld W, von Essen R, Effert S (1977) Familiäre asymmetrische Septumhypertrophie mit und ohne Obstruktion. Dtsch med Wschr 102:751PubMedCrossRefGoogle Scholar
  174. Hanrath P, Montz R, Mathey D, Verbringer H, Kupper W, Knop J, Bleifeld W, Schneider C (1978) Comparison between Thallium 201 myocardial szintigraphy, myocardial lactate metabolism and coronary angiography in hypertrophic obstructive cardiomyopathy. Circulation 57/58:11–130Google Scholar
  175. Hanrath P, Mathey D, Siegert R, Augustin J, Bleifeld W (1979) Abnormes Relaxations- und Füllverhalten des linken Ventrikels bei unterschiedlichen Hypertrophieformen. Z Kardiol 68:214PubMedGoogle Scholar
  176. Hanrath P, Mathey D, Siegert R et al (1980) Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: An echocardiographic study. Amer J Cardiol 45:15PubMedCrossRefGoogle Scholar
  177. Hanrath P, Mathey D, Kremer P, Sonntag F, Bleifeld W (1980) Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. Amer J Cardiol 45:1258PubMedCrossRefGoogle Scholar
  178. Hardarson T, Curiel R, De La Calzada CS, Goodwin JF (1973) Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 11:1462CrossRefGoogle Scholar
  179. Harrison D, Braunwald E, Glich G, Mason DT, Chidsey CA, Ross jr J (1964) Effects of ß-adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 29:84PubMedGoogle Scholar
  180. Harvey WP, Segal P (1967) Primary myocardial disease. Postgrad Med 42:144PubMedGoogle Scholar
  181. Harvey WP, Segal JP, Gurel T (1964) The clinical spectrum of primary myocardial disease. Progr cardiovasc Dis 7:1CrossRefGoogle Scholar
  182. Hauser AM, Gordon S, Cieszkowski J, Timmis GC (1983) Severe transient left ventricular “hypertrophy” occurring during acute myocarditis. Chest 83:275PubMedCrossRefGoogle Scholar
  183. Heinecker R (1959) Über die Häufigkeit kardialer Beteiligung bei Influenzainfektion. Verh dtsch Ges inn Med 65:788PubMedGoogle Scholar
  184. Henning H, O’Rourke RA, Crawford MH, Righetti A, Karliner JS (1978) Inferior myocardial infarction as a cause of asymmetric septal hypertrophy. Amer J Cardiol 41:817PubMedCrossRefGoogle Scholar
  185. Henry WL, Clark ChE, Epstein SE (1973 a) Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 47:225PubMedGoogle Scholar
  186. Henry WL, Clark CE, Epstein SE (1973 b) Asymmetric septal hypertrophy (ASH): The unifying link in the IHSS disease spectrum. Circulation 47:827PubMedGoogle Scholar
  187. Henry WL, Clark CE, Glancy DL, Epstein SE (1973 c) Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. New Engl J Med 288:989PubMedCrossRefGoogle Scholar
  188. Henry WL, Clark CE, Roberts WC, Morrow AG, Epstein SE (1974) Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Circulation 50:447PubMedGoogle Scholar
  189. Henry WL, Clark CE, Griffith JM, Epstein SE (1975) Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy. Amer J Cardiol 35:337PubMedCrossRefGoogle Scholar
  190. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, Epstein SE (1976) Relation between echo-cardiographically determined left atrial size and atrial fibrillation. Circulation 53:273PubMedGoogle Scholar
  191. Henry WL, Nienhuis AS, Wiener M, Miller DR, Canale VC, Piomelli S (1978) Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Amer J Med 64:547PubMedCrossRefGoogle Scholar
  192. Hess OM (1984) Klinik, Diagnostik und Therapie der Kardiomyopathien. Schweiz Rundschau Med (Praxis) 73, 26:817Google Scholar
  193. Hess OM, Krayenbühl HP (1982) Das Elektrokardiogramm bei den Kardiomyopathien. Schweiz med Wschr 112:333PubMedGoogle Scholar
  194. Hess OM, Turina J, Goebel N, Krayenbühl HP (1975) Funktionelle Gruppen der primären, nicht obstruktiven Kardiomyopathie. Z Kardiol Suppl 2:10Google Scholar
  195. Hess OM, Turina J, Krayenbühl HP (1977) Zur Diagnostik der Kardiomyopathien. Dtsch med Wschr 102:623PubMedCrossRefGoogle Scholar
  196. Hess OM, Goebel NH, Luescher H, Schneider J, Angehrn W, Krayenbühl HP (1979) Left ventricular function in patients with hypertrophic nonobstructive cardiomyopathy. Europ J Cardiol 9/2:129Google Scholar
  197. Hirschmann SZ, Hammer GS (1974) Coxsackie virus myopericarditis. A microbiological and clinical review. Amer J Cardiol 34:224CrossRefGoogle Scholar
  198. Holzmann M (1966) Die Bewertung der elektrokardiographi-schen Befunde bei der Myokarditis. Regensb Jb ärztl Fortbild 14:198Google Scholar
  199. Hopf R (1980) Die hypertroph obstruktive Kardiomyopathie (HOCM) und ihre Behandlung mit Kalzium-Antagonisten. Habilitationsarbeit, Frankfurt/MainGoogle Scholar
  200. Hopf R, Keller M, Kaltenbach M (1976) Die Behandlung der hypertrophen obstruktiven Kardiomyopathie mit Verapamil. Verh dtsch Ges Inn Med 82:1053Google Scholar
  201. Hopf R, Kober G, Kaltenbach M (1980) Die hypertroph obstruktive Kardiomyopathie (HOCM). Internistische Welt 3:394Google Scholar
  202. Hopf R, Kaltenbach M, Kober G (1981) Verapamil in the treatment of hypertrophic obstructive cardiomyopathy. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy — experience with verapamil. Excerpta Medica, Amsterdam Oxford Princeton, S 353Google Scholar
  203. Hopf R, Lemke R, Kober G, Kaltenbach M (1980) Klinische Ergebnisse der calciumantagonistischen Therapie bei Patienten mit hypertroph obstruktiver Kardiomyopathie. In: Fleckenstein A (ed) Calcium Antagonismus. Springer, Berlin Heidelberg New York, S 172CrossRefGoogle Scholar
  204. Hopf R, Hopf M, Kober G, Kaltenbach M, Riemann H (1975) Wertigkeit von Röntgenbefund und EKG in der Vorfelddiagnostik primärer Myokarderkrankungen. Z Kardiol Suppl 2:32Google Scholar
  205. Hort W (1968) Morphologie der akuten und chronischen Herzdilatation und Herzinsuffizienz. Verh dtsch Ges Kreisl-Forsch 34:1Google Scholar
  206. Hort W (1977) Morphologie der Kardiomyopathien. Röntgen-blätter 9:425Google Scholar
  207. Hudson RE (1970) The cardiomyopathies: Order from chaos. Amer J Cardiol 25:70PubMedCrossRefGoogle Scholar
  208. Hurst JW, Lugue RB (1974) The heart arteries and veins, 3rd ed. McGraw-Hill, New YorkGoogle Scholar
  209. Hutchins GM, Bulkley BH (1978) Catenoid shape of the interventricular septum: Possible cause of idiopathic hypertrophic subaortic stenosis. Circulation 58:392PubMedGoogle Scholar
  210. Ishiwata S, Nishyama S, Nakanishi S, Seki A (1993) Two types of left ventricular wall motion abnormalities with distinct clinical features in patients with hypertrophic cardiomyopathy. Eur Heart J 14:1629.PubMedCrossRefGoogle Scholar
  211. Jackson G, Richardson PJ, Atkinson N, Armstrong P, Oram S (1978) Angina with normal coronary arteriograms, value of coronary sinus lactate estimation in diagnosis and treatment. Brit Heart J 40:976PubMedCrossRefGoogle Scholar
  212. Jeanrenaud X, Goy JJ, Kappenberger L (1992) Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339:1318PubMedCrossRefGoogle Scholar
  213. Jocob AH, McLaren KM, Boon NA (1991) Effects of abstinence on alcoholic heart muscle disease. Am J Cardiol 68:805CrossRefGoogle Scholar
  214. Johansen A (1966) Isolated myocarditis versus myocardial sarcoidosis. Acta path microbiol scand 67:15PubMedGoogle Scholar
  215. Jones M, Ferrans VJ, Morrow AG, Roberts WC (1975) Ultrastructure of crista supraventricularis muscle in 37 patients with congenital heart disease associated with right ventricular outflow tract obstruction. Circulation 51:39PubMedGoogle Scholar
  216. Julian OC, Dye WS, Javid H, Hunter JA, Muenster J J, Najafi H (1965) Apical left ventriculotomy in subaortic stenosis due to a fibromuscular hypertrophy. Circulation 31, Suppl 1–45Google Scholar
  217. Jüngst BK (1966) Die myokardiale Sarcoidose. Z Kinderheilk 95:53PubMedCrossRefGoogle Scholar
  218. Kaltenbach M (1977) Therapie der hypertrophischen obstruktiven Cardiomyopathie mit Calciumantagonisten. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathies and myocardial biopsy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  219. Kaltenbach M, Hopf R (1982) Konservative medikamentöse Behandlung der hypertrophen Myokardiopathie. Z Kardiol 71:795PubMedGoogle Scholar
  220. Kaltenbach M, Hopf R, Keller M (1976) Calciumantagonistische Therapie bei hypertroph obstruktiver Kardiomyopathie. Dtsch med Wschr 101:1284PubMedCrossRefGoogle Scholar
  221. Kaltenbach M, Hopf R, Petersen Y, Kober G (1977) Verminderung des Koronararterienquerschnitts unter konservativer Therapie der hypertroph obstruktiven Kardiomyopathie. Verh dtsch Ges Kreisl-Forsch 43:358CrossRefGoogle Scholar
  222. Kaltenbach M, Hopf R, Kober C, Bussmann W-D, Keller M, Petersen Y (1978) Verapamil treatment of hypertrophic obstructive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, S 316CrossRefGoogle Scholar
  223. Kaltenbach M, Hopf R, Kober G, Bussmann W-D, Keller M, Petersen Y (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Brit Heart J 42:35PubMedCrossRefGoogle Scholar
  224. Kaplan MH, Bolandi R, Ratika L, Blair S (1964) Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. New Engl J Med 271:637PubMedCrossRefGoogle Scholar
  225. Kazamias TM, Gander MP (1973) Left ventricular wall motion disorders, functional left ventricular aneurysm. Amer J Cardiol 32:151PubMedCrossRefGoogle Scholar
  226. Kemp HG, Vokonas S, Cohn PF, Gorlin R (1973) The anginal syndrome associated with normal coronary arteriograms. Amer J Med 54:735PubMedCrossRefGoogle Scholar
  227. King JF, DeMaria AN, Reis RL, Bolton MR, Dunn MI, Mason DT (1973) Echocardiographic assessment of idiopathic hypertrophic subaortic stenosis. Chest 64:723PubMedCrossRefGoogle Scholar
  228. King JF, DeMaria AN, Miller RR, Hilliard GK, Zelis R, Mason DT (1974) Markedly abnormal mitral valve motion without simultaneous intraventricular pressure gradient due to uneven mitral-septal contract in idiopathic hypertrophic subaortic stenosis. Amer J Cardiol 34:360PubMedCrossRefGoogle Scholar
  229. Kirklin JW, Ellis FH Jr (1961) Surgical relief of diffuse subval-vular aortic stenosis. Circulation 24:739PubMedGoogle Scholar
  230. Knieriem H-J (1977) Electron microscopic findings in congestive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathies and myocardial biopsy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  231. Knieriem H-J (1979) Myokardiopathien. In: Büchner F, Grundmann E (eds) Lehrbuch der speziellen Pathologie, S 38. Ur-ban&Schwarzenberg, München Wien BaltimoreGoogle Scholar
  232. Knieriem H-J, Kuhn H, Breithardt G (1975) Zur Diagnostik der primären Kardiomyopathien mit Hilfe der Myokardbiopsie. Z Kardiol Suppl 2:26Google Scholar
  233. Knieriem H-J, Stroobandt R, Meyer H, Bourgeois M (1975) Hypertrophie non-obstructive cardiomyopathy caused by disorder of the myofiber texture. Virchows Arch 367:209Google Scholar
  234. Kober G, Becker HJ, Bussmann WD, Kaltenbach M (1975) Die Myokardbiopsie in der Diagnostik der Kardiomyopathien. Technische Aspekte und Komplikationen. Z Kardiol Suppl 2:23Google Scholar
  235. Köberle I (1968) Chagas heart disease-pathology. Cardiologica (Basel) 52:82Google Scholar
  236. Kochsiek K (1975) Klassifizierung der Kardiomyopathien. Z Kardiol Suppl 2:2Google Scholar
  237. Kochsiek K, Larbid D, Harmjanz D (1971a) Die hypertrophische obstruktive Kardiomyopathie. Experimentelle Medizin, Pathologie und Klinik, Bd 35. Springer, BerlinCrossRefGoogle Scholar
  238. Kochsiek K, Tauchert M, Strauer BE, Heiss HW (1971b) Koronarreserve und O2-Verbrauch bei hypertrophischer obstruktiver Kardiomyopathie. Verh dtsch Ges inn Med 77:880PubMedGoogle Scholar
  239. Köhler E, Kuhn H, Bluschke V, Haerten K, Loogen F (1979 a) Seltene echokardiographische Befunde bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol 68:271Google Scholar
  240. Köhler E, Thurow J, Kuhn H, Neuhaus C, Bluschke V, Bosilj M (1979 b) Klinische und echokardiographische Untersuchungen zur familiären Verbreitung der hypertrophisch obstruktiven HOCM) und hypertrophisch nicht obstruktiven (HNCM) Kardiomyopathie. Z Kardiol 68:511PubMedGoogle Scholar
  241. Konecke LL, Feigenbaum H, Chang S, Corya BC, Fischer JC (1973) Abnormal mitral valve motion in patients with elevated left ventricular diastolic pressures. Circulation 47:989PubMedGoogle Scholar
  242. Koontz CH, Ray CG (1971) The role of Coxsackie group virus infections in sporadic myopericardcitis. Amer Heart 82:750CrossRefGoogle Scholar
  243. Körfer R, Schulte HD, Bircks W (1975) Zur operativen Behandlung der idiopathischen hypertrophischen Subaortenstenose (IHSS). Z Kardiol Suppl 2:2Google Scholar
  244. Kostis JB, Moreyra AE, Natarajan N et al (1979) The pathophysiology and diverse etiology of septal perforator compression. Circulation 59:913PubMedGoogle Scholar
  245. Krajcer Z, Orzan F, Pechacek LW, Garcia F, Leachman RD (1978) Early systolic closure of the aortic valve in patient with hypertrophic subaortic stenosis and discrete subaortic stenosis. Amer J Cardiol 41:823PubMedCrossRefGoogle Scholar
  246. Krasnow N, Stein RA (1978) Hypertrophic cardiomyopathy in the aged. Amer Heart J 96:326PubMedCrossRefGoogle Scholar
  247. Krelhaus W, Kuhn H, Loogen F (1977) Todesfälle bei hypertrophischer obstruktiver Myokardiopathie. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathies and myocardial biopsy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  248. Kreulen TH, Gorlin R, Herman MV (1973) Ventriculographic patterns and hemodynamics in primary myocardial disease. Circulation 47:299PubMedGoogle Scholar
  249. Kronik G, Litpak V, Mösslacher H, Slany J, Ehrenböck R (1979) Echokardiographische Kriterien für die Differentialdiagnose zwischen kongestiver Kardiomyopathie und koronarer Herzkrankheit bei Patienten mit Kardiomegalie. Herz/Kreisl 11:483Google Scholar
  250. Kronik G, Mösslacher H, Schmoliner R (1981) Differentialdiagnose zwischen diffusen Myokarderkrankungen und koronarer Herzkrankheit mit Hilfe der zweidimensionalen Echokardiographie. Herz/Kreisl 3:113Google Scholar
  251. Kubier W, Kuhn H, Loogen F (1973) Zur klinischen Einteilung der Cardiomyopathien. Dtsch med Wschr 97:1834Google Scholar
  252. Kubier W, Kuhn H, Loogen F (1973) Die Cardiomyopathien. Z Kardiol 62:3Google Scholar
  253. Kubier W, Zebe H, Tillmanns D, Zekl G (1975) Die congestive Cardiomyopathie. Z Kardiol Suppl 2:4Google Scholar
  254. Kuhn E (1977) Die Bedeutung der Vererbung bei Kardiomyopathien. Klin Wschr 55:673PubMedCrossRefGoogle Scholar
  255. Kuhn H (1981) Invasive Diagnostik bei Kardiomyopathien. Verh dtsch Ges Herz-Kreisl-Forsch 47:217Google Scholar
  256. Kuhn H (1982) Left ventricular hypertrophy in clinical practice: Cardiomyopathies. Europ Heart J 3:187Google Scholar
  257. Kuhn H (1982) Treatment of hypertrophic cardiomyopathies. In: Epstein E, Kaltenbach M (eds) Verapamil treatment of hypertrophic cardiomyopathy, S 160. Springer, Berlin Heidelberg New YorkGoogle Scholar
  258. Kuhn H, Loogen F (1978 b) Die Anwendung von Betarezepto-renblockern bei hypertrophischer obstruktiver Kardiomyopathie (HOCM). Internist 19:527PubMedGoogle Scholar
  259. Kuhn H, Loogen F (1978 c) Die Wirkung von Alkohol auf das Herz einschließlich der Alkoholkardiomyopathie. Internist 19:97PubMedGoogle Scholar
  260. Kuhn H, Loogen F (1981) Erkrankungen des Myokards. In: Krayenbühl HP, Kubier W (eds) Kardiologie in Klinik und Praxis, Bd II. Thieme, StuttgartGoogle Scholar
  261. Kuhn H, Krelhaus W, Loogen F (1977) Indication for surgical treatment of hypertrophic obstructive cardiomyopathy. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathies and Myocardial Biopsy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  262. Kuhn H, Hust MH, Breithardt G, Wiebringhaus E (1976) Zur Frage der kardiodepressiven Wirkung geringer Mengen von Alkohol bei Normalpersonen und Patienten mit koronarer Herzerkrankung. Z Kardiol 65:1071PubMedGoogle Scholar
  263. Kuhn H, Haensch R, Lösse B, Jehle J (1977 a) Hypertrophische obstruktive Cardiomyopathie und Lentiginosis. Dtsch med Wschr 18:679CrossRefGoogle Scholar
  264. Kuhn N, Breithardt G, Knieriem H-J, Loogen F (1978 a) Endomyocardial catheter biopsy in heart disease of unknown etiology. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and Myocardial Biopsy, S 121. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  265. Kuhn H, Thelen U, Köhler E, Lösse B (1980) Die hypertrophische nicht obstruktive Kardiomyopathie (HNCM) — klinische, hämodynamische, elektro-, echo- und angiographische Untersuchungen. Z Kardiol 69:457PubMedGoogle Scholar
  266. Kuhn E, Köhler E, Hort W, Frenzel H (1982) Concealed myocardial storage disease (Fabry’s disease): Pitfalls in the diagnosis of hypertrophic non obstructive cardiomyopathy. Circulation 66:117Google Scholar
  267. Kuhn H, Loogen F, Breithardt G, Seipel L, Krelhaus W (1977) Die Kardiomyopathien. In: Diethelm L, Olsen O, Strand F, Vieten H, Zuppinger A (eds) Handbuch der medizinischen Radiologie, S 261. Springer, Berlin Heidelberg New YorkGoogle Scholar
  268. Kuhn H, Thelen U, Leuner C, Köhler E, Bluschke V (1980) Langzeitbehandlung der hypertrophischen nicht obstruktiven Kardiomyopathie (HNCM) mit Verapamil. Z Kardiol 69:669PubMedGoogle Scholar
  269. Kuhn H, Lösse B, Becker R, Curtius JM, Köhler E, Loogen F (1981) Die congestive (dilatative) Kardiomyopathie aus allgemein klinischer Sicht. Z Kardiol 70:604Google Scholar
  270. Kuhn H, Breithardt G, Knieriem H-J, Loogen F, Both A, Schmidt WA, Stroobandt R (1975 b) Die Bedeutung des Elektrokardiogramms und der endomyokardialen Katheter-biopsie für Diagnose und Verlaufsbeobachtung der congesti-ven Kardiomyopathie. Verh dtsch Ges inn Med 81:211PubMedGoogle Scholar
  271. Kuhn H, Breithardt G, Knieriem H-J, Köhler E, Lösse B, Seipel L, Loogen F (1978 b) Prognosis and possible presymp-tomatic manifestations of congestive cardiomyopathy. Postgrad Med J 54:451PubMedCrossRefGoogle Scholar
  272. Kuhn H, Becker R, Fischer J, Curtius JM, Lösse B, Hort W, Loogen F (1982) Untersuchungen zur Ätiologie, zum Verlauf und zur Prognose der dilatativen Kardiomyopathie (DCM). Z Kardiol 71:497PubMedGoogle Scholar
  273. Kuhn H, Breithardt G, Knieriem H-J, Loogen F, Both A, Schmidt, WA, Stroobandt R, Gleichmann U (1975 a) Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und Beurteilung der Prognose bei congestiver Cardiomyopathie. Dtsch med Wschr 100:717, 743PubMedCrossRefGoogle Scholar
  274. Kuhn H, Gietzen F, Mercier J, Lösse B, Köhler E, Schulte HD, Birks W, Loogen F (1983) Untersuchungen zur Klinik, zum Verlauf und zur Prognose verschiedener Formen der hypertrophischen Kardiomyopathie. Z Kardiol 72:83PubMedGoogle Scholar
  275. Kunkel B, Kober G, Lapp H, Leuschner U, Kaltenbach M (1975) Vergleich klinischer, licht- und elektronenmikroskopischer Befunde bei Kardiomyopathien. Z Kardiol Suppl 2:27Google Scholar
  276. Kunkel B, Kober G, Lapp H, Leuschner U, Kaltenbach M (1977) Klinische, licht- und elektronenmikroskopische Befunde bei frühen und fortgeschrittenen Formen kongestiver Kardiomyopathien. Z Kardiol 66:198PubMedGoogle Scholar
  277. Kunkel B, Lapp H, Kober G, Kaltenbach M (1978) Correlations between clinical and morphologic findings and natural history in congestive cardiomyopathy. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and Myocardial Biopsy, S 271. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  278. Kunkel B, Schneider M, Kober G, Bussmann WD, Hopf R, Kaltenbach M (1982) Die Morphologie der Myokardbiopsie und ihre klinische Bedeutung. Z Kardiol 71:787PubMedGoogle Scholar
  279. Larter WE, Allen HD, Sahn DJ, Goldberg SJ (1976) The asymmetrically hypertrophied septum. Further differentiation of its causes. Circulation 53:19PubMedGoogle Scholar
  280. Lattanui F, Spirito P, Picano E et al (1991) Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. J Am Coll Cardiol 17:1085CrossRefGoogle Scholar
  281. Lauer B, Padberg K, Schultheiss HP, Strauer BE (1995) Autoantikörper gegen kardiales Myosin bei Patienten mit Myokarditis und dilatativer Kardiomyopathie. Z Kardiol 84:301PubMedGoogle Scholar
  282. Laurenceau JL, Cérèze P, Dumesnil J-G (1979) Surveillance échocardiographique des myocardites: mise en évidence de dysfonction régionale. Ceour et médecine interne 18:451Google Scholar
  283. Lerner AM, Wilson FM (1973) Virus myocardiopathy. Progr med Virol 15:63Google Scholar
  284. Levander-Lindgren M (1965) Studies in myocarditis. IV. Late prognosis. Cardiologia (Basel) 47:209Google Scholar
  285. Lewis BS, Gotsman MS (1973) Selective coronary angiography in primary myocardial disease. Brit Heart J 35:165PubMedCrossRefGoogle Scholar
  286. Linhart JW, Taylor WJ (1966) Bacterial endocarditis in a patient with idiopathic hypertrophic subaortic stenosis. Circulation 34:595PubMedGoogle Scholar
  287. Linzbach A J (1960 a) Heart failure from the point of view of quantitative anatomy. Amer J Cardiol 5:370PubMedCrossRefGoogle Scholar
  288. Linzbach A J (1960 b) Die pathologische Anatomie der Herzinsuffizienz. In: Schwiegk H (ed) Handbuch der inneren Medizin, Bd 9/1, S 706. Springer, Berlin Göttingen HeidelbergGoogle Scholar
  289. Linzbach AJ (1968) Eröffnungsrede des Tagungsvorsitzenden. Verh dtsch Ges Kreisl-Forsch 34:38Google Scholar
  290. Linzbach AJ, Kyrieleis C (1968) Strukturelle Analyse chronisch insuffizienter menschlicher Herzen. In: Reindell H, Keul J, Doli E (eds) Herzinsuffizienz. Internationales Symposium, 2.–5.11.1957, Hinterzarten, Sil. Thieme, StuttgartGoogle Scholar
  291. Lockhart A, Charpentier A, Bourdarias JP et al (1966) Right ventricular involvement in obstructive cardiomyopathies: Hemodynamic studies in 13 cases. Brit Heart J 28:122PubMedCrossRefGoogle Scholar
  292. Löffler W (1936) Endocarditis parietalis fibroplastica mit Blut-eosinophilie. Ein eigenartiges Krankheitsbild. Schweiz med Wschr 66:817Google Scholar
  293. Loogen F (1986) Klinik, Therapie und Prognose der hypertrophen obstruktiven Kardiomyopathie. Symposium Bundesgesundheitsamt: Zur kritischen Bewertung experimenteller Befunde auf dem Herz-Kreislauf-Sektor für den Menschen. BerlinGoogle Scholar
  294. Loogen F (1987) Mittlerer Druckgradient 50 mmHg bezogen auf 260 Untersuchungen: Literaturangaben und eigene Beobachtungen. Persönl MitteilungGoogle Scholar
  295. Loogen F, Kuhn H (1975) Kardiomyopathien ungeklärter Ätiologie (sog. primäre Kardiomyopathien). Internist 16:540PubMedGoogle Scholar
  296. Loogen F, Krelhaus W, Kubier W (1974) Natural history of hypertrophic obstructive cardiomyopathy: Observations on 107 patients. In: Bajuz E, Rona G, (eds) Cardiomyopathies, S 629. Urban&Schwarzenberg, MünchenGoogle Scholar
  297. Loogen F, Krelhaus W, Kuhn H (1975) Die hypertrophische obstruktive Myokardiopathie (HOCM). Z Kardiol Suppl 2:3Google Scholar
  298. Loogen F, Krelhaus W, Kuhn H (1976) Die hypertrophische obstruktive Kardiomyopathie. Münch med Wschr 118:745Google Scholar
  299. Loogen F, Kuhn H, Krelhaus W (1976) Follow-up studies in patients with hypertrophic obstructive cardiomyopathy. 7th European Congress of Cardiology, AmsterdamGoogle Scholar
  300. Loogen F, Kuhn H, Neuhaus LK (1976 a) Störungen der Ventrikelfunktion bei Kardiomyopathien. Verh dtsch Ges Kreisl-Forsch 42:63Google Scholar
  301. Loogen F, Krelhaus W, Kuhn H (1976 b) Verlaufsbeobachtungen der hypertrophischen obstruktiven Cardiomyopathie. Z Kardiol 65:511PubMedGoogle Scholar
  302. Loogen F, Kuhn H, Krelhaus W (1977) Follow up studies in patients with hypertrophic obstructive cardiomyopathy. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathies and myocardial biopsy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  303. Loogen F, Kuhn H, Krelhaus W (1978) Natural history of hypertrophic obstructive cardiomyopathy and the effects of therapy. In: Klatenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy, S 286. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  304. Lorell BH, Aldermann EL, Mason JW (1978) Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Amer J Cardiol 42:143PubMedCrossRefGoogle Scholar
  305. Lorell BH, Paulus WJ, Grossman W et al (1982) Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65:499PubMedCrossRefGoogle Scholar
  306. Lösse B, Kuhn H, Loogen F (1982) Klinische und hämodynami-sche Effekte von Verapamil bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol 71:813PubMedGoogle Scholar
  307. Lösse B, Kuhn H, Loogen F (1982) Functional results in medically and surgically treated patients with hypertrophic obstructive cardiomyopathy. In: Klatenbach M, Epstein SE (eds) Hypertrophic Cardiomyopathy, S 251. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  308. Lösse B, Kuhn H, Bircks W, Loogen F (1981) Hemodynamic effects of different therapeutic trials in hypertrophic obstructive cardiomyopathy — verapamil, propranolol, and surgical therapy. Europ Heart J 2 (Suppl A):59Google Scholar
  309. Lösse B, Kuhn H, Rafflenbeul D, Krönert H, Bircks W, Loogen F (1981) Verapamil im Vergleich zu Propranolol und chirurgischer Therapie bei obstruktiver Kardiomyopathie (HOCM). Z Kardiol 70:626 (abstract)Google Scholar
  310. Lösse B, Kuhn H, Krönert H, Rafflenbeul D, Köhler E, Schicha H, Feinendegen LE (1979) Hämodynamische und radiokar-diographische Belastungsuntersuchungen bei Patienten mitkomplettem Linksschenkelblock und normal großem Herzen. Z Kardiol 68:304PubMedGoogle Scholar
  311. Lösse B, Kuhn H, Rafflenbeul D, Krönert H, Hort W, Feinendegen LE, Loogen F (1980) Scintigraphic myocardique au thallium-201 chez des patients à coronaires et ventriculographies normales. Ann Cardiol Angeiol 29:265Google Scholar
  312. Lösse B, Kuhn H, Krönert H, Rafflenbeul D, Kirschner P, Schulte HD, Loogen F (1980) Hämodynamische Auswirkungen konservativer und operativer Therapie bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol 69:470PubMedGoogle Scholar
  313. MacArthur CGC, Binbrek AS, Chetty S, Sanderson JE, Fitchett DH, Goodwin JF, Oakley CM (1981) The effect of left ventricular function, arrhythmias and evidence of previous viral infection on the prognosis of congestive cardiomyopathy. In: Goodwin JF, Hjalmarson A, Olsen EGH (eds) Congestive cardiomyopathy, S 236. Schweden: Acta cardiovascularGoogle Scholar
  314. Maire R, Hess OM, Pult I, Schneider J, Krayenbühl HP (1987) Die äthylische Kardiomyopathie: ein Vergleich zur dilatati-ven Kardiomyopathie. Schweiz Rundschau Med (Praxis) 76:3, 37Google Scholar
  315. Maisch B (1984) Die dilatative Kardiomyopathie. Herz u Gefäße 4:73Google Scholar
  316. Marcus GB, Popp RL, Stinson EB (1974) Coronary-artery disease with idiopathic hypertrophic subaortic stenosis. Lancet 1:901PubMedCrossRefGoogle Scholar
  317. DeMaria AN, Bommer W, Lee G, Mason DT (1980) Value and limitations of two dimensional echocardiography in assessment of cardiomyopathy. Amer J Cardiol 46:1224PubMedCrossRefGoogle Scholar
  318. Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59:689PubMedGoogle Scholar
  319. Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Amer J Cardiol 43:1086PubMedCrossRefGoogle Scholar
  320. Maron BJ, Roberts WC, Epstein SE (1985) Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 65:1388CrossRefGoogle Scholar
  321. Maron BJ, Henry WL, Roberts WC, Epstein SE (1977) Comparison of echocardiographic and necropsy measurements of ventricular wall thickness in patients with and without disproportionate septal thickening. Circulation 55:341PubMedGoogle Scholar
  322. Maron BJ, Edwards JE, Henry WL et al (1974) Asymmetric septal hypertrophy (ASH) in infancy. Circulation 50:809PubMedGoogle Scholar
  323. Maron BJ, Redwood DR, Roberts WC, Henry WL, Morrow AG, Epstein SE (1976) Tunnel subaortic stenosis — Left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation 54:404PubMedGoogle Scholar
  324. Maron BJ, Henry WL, Clark CF, Redwood DR, Roberts WC, Epstein SE (1976) Asymmetric septal hypertrophy in childhood. Circulation 53:9PubMedGoogle Scholar
  325. Maron BJ, Roberts WC, Edwards JE, McAllister jr HA, Foley DD, Epstein SE (1978) Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitation. Amer J Cardiol 41:803PubMedCrossRefGoogle Scholar
  326. Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG (1978) Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 57:1205PubMedGoogle Scholar
  327. Maron BJ, Roberts WC, McAllister jr HA, Rosing DR, Epstein SE (1980) Sudden death in young athletes. Circulation 62:218PubMedGoogle Scholar
  328. Maron BJ, Ferrans VJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Morrow AG, Epstein SE (1974) Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light and electronmicroscopic findings. Circulation 50:436PubMedGoogle Scholar
  329. Maron BJ, Clark CE, Henry WL, Fokuda T, Edwards JE, Mathews EC, Redwood DR, Epstein SE (1977) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with aquired or congenital heart disease. Circulation 55:489PubMedGoogle Scholar
  330. Maron BJ, Lipson LC, Roberts WC et al (1978) “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death. Amer J Cardiol 41:1133PubMedCrossRefGoogle Scholar
  331. Maron BJ, Tajik A J, Ruttenberg HD et al (1982) Hypertrophic cardiomyopathy in infants: Clinical features and natural history. Circulation 65:7PubMedCrossRefGoogle Scholar
  332. Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 65:1388PubMedCrossRefGoogle Scholar
  333. Martin RP, Rakowski H, French J, Popp RL (1979) Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phas-ed-array echocardiography. Circulation 59:1206PubMedGoogle Scholar
  334. Massie BM, Schiller NB, Ratshin RR, Parmley WW (1977) Mitral septal separation: New echocardiographic index of left ventricular function. Amer J Cardiol 39:1008PubMedCrossRefGoogle Scholar
  335. Mathes P, Sebening H, Delius W, Wirtzfeld A (1975) Regionales Kontraktionsverhalten bei kongestiver Kardiomyopathie. Z Kardiol Suppl 2:9Google Scholar
  336. Mathes P, Delius W, Sebening H, Wirtzfeld A, Blömer H (1976) Das regionale Kontraktionsverhalten der linken Herzkammer bei kongestiver Cardiomyopathie. Dtsch med Wschr 101:995PubMedCrossRefGoogle Scholar
  337. Matsui Y, Kazvoiswai T, Taukibana T, Frive T (1976) Clinico-pathological study of total myocardial sarcoidosis. Ann NY Acad Sci 278:455PubMedCrossRefGoogle Scholar
  338. Matsuonka Y, Kitamura K, Nishiguchi T, Hayakawa K (1989) Transient myocardial thickening in acute myocarditis -serial study by two-dimensional echocardiography. Acta Paediatr Jpn 31:216CrossRefGoogle Scholar
  339. Mattingly TW (1958) The clinical and hemodynamic features of primary myocardial disease. Trans Amer clin climatol Ass 70:132Google Scholar
  340. Mattingly TW (1961) Clinical features and diagnosis of primary myocardial disease. Mod Cone cardiovasc Dis 30:677Google Scholar
  341. Mattingly TW (1970) Diseases of the myocardium (cardiomyopathies): The viewpoint of a clinical cardiologist. Amer J Cardiol 25:79PubMedCrossRefGoogle Scholar
  342. May G (1975) Virusätiologie der Myokarditis. Diagnostik 8:182Google Scholar
  343. McDonald IG, Feigenbaum H, Chang S (1972) Analysis of left ventricular wall motion by reflected ultrasound. Application to assessment of myocardial function. Circulation 46:14PubMedGoogle Scholar
  344. McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 h ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Amer J Cardiol 45:1PubMedCrossRefGoogle Scholar
  345. McKenna WS, Oakley CM, Krikler DM, Goodwin JF (1985) Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 53:412PubMedCrossRefGoogle Scholar
  346. Meessen H (1971 a) Structural basis of myocardial hypertrophy. Brit Heart J Suppl 33:94CrossRefGoogle Scholar
  347. Meessen H (1971b) Morphologie der Myokardhypertrophie. Verh dtsch Ges inn Med 77:43PubMedGoogle Scholar
  348. Meessen H (1974) Über Herzhypertrophie. Lebensversicherungsmedizin 26:102PubMedGoogle Scholar
  349. Meessen H, Poche R (1967) Beiträge zur pathologischen Anatomie der Fallotschen Fehler und zur idiopathischen Herzhypertrophie. Dtsch-engl med R 4:73Google Scholar
  350. Meinertz T, Hohnloser S, Zehender M, Geibel A, Just H (1987) Plötzlicher Herztod — wie erkennt man gefährdete Patienten? Z Kardiol 76, Suppl 2Google Scholar
  351. Menapace FJ, Hammer WJ, Kessler KK, Ritzer T, Bove AA, Warner HH, Spann JF (1977) Echocardiographic measurements of left ventricular wall thickness in weight lifters: A problem with the definition of ASH. Amer J Cardiol 39:276Google Scholar
  352. v Mengden H-J, Reck R, Lorey-Ammann S, Strasser R (1982) Das Elektrokardiogramm bei Kardiomyopathien. Herz/ Kreisl 12:631Google Scholar
  353. Menges jr H, Brandenburg RO, Brown jr AL (1961) The clinical, hemodynamic, and pathologic diagnosis of muscular subvalvular aortic stenosis. Circulation 24:1126PubMedGoogle Scholar
  354. Messer JV, Neill WA (1962) The oxygen supply of human heart. Amer J Cardiol 9:384PubMedCrossRefGoogle Scholar
  355. Messmer B (1986) Hypertroph-obstruktive Kardiomyopathie — Wann ein Fall für den Chirurgen? Med Trib 17Google Scholar
  356. Mikhail JR et al (1975) Abnormal electrocardiographic findings in sarcoidosis. Proc VI ICS Univ Tokyo Press 365Google Scholar
  357. Mintz HS, Kotler MN, Segal BL, Parry WR (1976) Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy (Abstract). Circulation 53/54 (Suppl II):191Google Scholar
  358. Mintz HS, Kotler MN, Segal BL, Parry WR (1978) Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy. Circulation 57:256PubMedGoogle Scholar
  359. Mirsky I, Cohn PF, Levine JA, Gorlin R, Hermann MV, Kreulen TH, Sonnenblick EH (1974) Assessment of left ventricular stiffness in primary myocardial disease and coronary artery disease. Circulation 50:128PubMedGoogle Scholar
  360. Mohr R, Schaff HV, Danielson GK et al (1989) The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 97:666PubMedGoogle Scholar
  361. Moreyra E, Klein JJ, Shinada H, Segal BL (1969) Idiopathic hypertrophic subaortic stenosis diagnosed by reflected ultrasound. Amer J Cardiol 23:32PubMedCrossRefGoogle Scholar
  362. Morganroth J, Henry WL, Maron BJ, Clark CE, Epstein SE (1974) Idiopathic left ventricular hypertrophy. Echocardiographic evidence against its existence. New Engl J Med 290:1047PubMedCrossRefGoogle Scholar
  363. Morganroth J, Maron BJ, Henry WL, Epstein SE (1975) Comparative left ventricular dimensions in trained athletes. Ann intern Med 82:521PubMedGoogle Scholar
  364. Morrow AG (1969) Hypertrophic subaortic stenosis: Some physiologic concepts and the role of operative treatment. Arch Surg 99:677PubMedCrossRefGoogle Scholar
  365. Morrow AG (1978) Hypertrophic subaortic stenosis: Operative methods utilized to relieve left ventricular outflow obstruction. J thorac cardiovasc Surg 76:423PubMedGoogle Scholar
  366. Morrow AG, Braunwald E (1959) Functional aortic stenosis: A malformation characterized by resistance to left ventricular outflow without anatomic obstruction: Circulation 20:181PubMedGoogle Scholar
  367. Morrow AG, Brockenbrough EC (1961) Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 154:181PubMedCrossRefGoogle Scholar
  368. Morrow AG, Fisher RD, Fogarty TJ (1969) Isolated hypertrophic obstruction to right ventricular outflow: Clinical, hemodynamic, and angiographic findings before and after operative treatment. Amer Heart J 77:814PubMedCrossRefGoogle Scholar
  369. Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR (1975) Operative treatment in hypertrophic subaortic stenosis: Techniques and the results of pre- and postoperative assessments in 83 patients. Circulation 52:88PubMedGoogle Scholar
  370. Morrow AG, Koch J-P, Maron BJ et al (1980) Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest. Amer J Cardiol 46:313PubMedCrossRefGoogle Scholar
  371. Murgo JP, Alter BR, Dorethy JR et al (1980) Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J clin Invest 66:1369PubMedCrossRefGoogle Scholar
  372. Nanda NC, Gramiak R, Shah PM, Stewart S, DeWeese JA (1974) Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co-existing with aortic valve disease. Circulation 50:752PubMedGoogle Scholar
  373. Neufeld HN, Ongley PA, Edwards JE (1960) Combined congenital subaortic stenosis and infundibular pulmonary stenosis. Brit Heart J 22:686PubMedCrossRefGoogle Scholar
  374. Nieminen MS, Heikkilä J, Karjalainen J (1984) Echocardiography in acute infectious myocarditis: Relation to clinical and electrocardiographic findings. Am J Cardiol 53:1331PubMedCrossRefGoogle Scholar
  375. Nimura Y, Nagata S, Sakakibara H, Beppu S, Park YD, Kinoshita A, Miyatake K (1980) Newer aspects in hypertrophic cardiomyopathy, studied with cross-sectional echocardiography. In: Sekiguchi M, Olsen EGJ (eds) Cardiomyopathy. Clinical, Pathological and Theoretical Aspects, S 13. University Park Press, BaltimoreGoogle Scholar
  376. Van Noorden S, Olsen EGJ, Pearse AGE (1971) Hypertrophic obstructive cardiomyopathy, a histological, histochemical and ultrastructural study of biopsy material. Cardiovasc Res 5:118PubMedCrossRefGoogle Scholar
  377. Oakley CM (1972) Clinical definitions and classification of cardiomyopathies. Postgrad med J 48:703PubMedCrossRefGoogle Scholar
  378. Oakley CM (1974) Clinical recognition of the cardiomyopathies. Circulât Res Suppl 11:152Google Scholar
  379. Oakley CM (1975) Surgical correction of ASH (letter to the editor). Circulation 51:951PubMedGoogle Scholar
  380. Oakley CM (1978) Diagnosis and natural history of congested (dilated) cardiomyopathies. Postgrad med J 54:440PubMedCrossRefGoogle Scholar
  381. Olsen EGJ (1972) Pathology of primary cardiomyopathies. Postgrad med J 48:732PubMedCrossRefGoogle Scholar
  382. Olsen EGJ (1978) Zur Pathologie der Kardiomyopathien. Schwerpunkt Medizin 2:103Google Scholar
  383. Olsen EGJ, Trotter SE (1993) Pathology. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 85–93CrossRefGoogle Scholar
  384. Olsen EGJ, Trotter SE (1993) Pathology. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 165–172CrossRefGoogle Scholar
  385. Opherk D, Zebe H, Schuler G, Weihe E, Mall G, Mehmel H, Gravert B, Kubier W (1980) Reduced coronary reserve and impaired exercise left ventricular performance on patients with syndrome x. In: Kubier W, Tillmanns H, Zebe H (eds) Microcirculation of the Heart — Theoretical and Clinical Problems. Springer, Berlin Heidelberg New YorkGoogle Scholar
  386. Pachinger O, Klicpera M, Sochor H, Probst P, Kaliman J, Dogar D, Mayr H, Miczoch J, Kaindl F (1982) Hämodynamik der kongestiven Kardiomyopathie. Z Kardiol 71:509PubMedGoogle Scholar
  387. Packer M (1995) The PRAISE Trial (Prospective Randomized Amlodipine Survival Evaluation) Background and main results. 44th Annual Scientific Session, American College of Cardiology, 610Google Scholar
  388. Parillo JE, Borsy GC, Mazur MH, Iannini P, Klempner MS, Moellering RC, Anderson SE (1979) Endocarditis due to resistant viridans streptococci during oral penicillin chemo-prophylaxis. New Engl J Med 300:296CrossRefGoogle Scholar
  389. Parker JO, West RO, Case RB, Chiong MA (1969) Temporal relationships of myocardial lactate metabolism, left ventricular function, and ST-segment depression during angina precipitated by exercise. Circulation 40:97PubMedGoogle Scholar
  390. Petersen J, Rentrop P, Schnellbacher K, Roskamm H, Nitsche K (1975) Hämodynamik und Ventrikelmechanik bei nicht ko-ronarbedingter Myokarderkrankung. Z Kardiol Suppl 2:11Google Scholar
  391. Pichard AD, Melier J, Teichholz LE et al (1977) Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis. Amer J Cardiol 40:310PubMedCrossRefGoogle Scholar
  392. Pitcher D, Wainwright R, Maisey M et al (1980) Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Brit Heart J 44:650PubMedCrossRefGoogle Scholar
  393. Poche R (1982) Pathologie der Kardiomyopathien und Myokardiopathien. In: Roskamm H, Reindell H (eds) Herzkrankheiten, 2. Aufl., S 1055. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  394. Popp RL, Harrison DC (1969) Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis. Circulation 50:905Google Scholar
  395. Rakowski H, Boughner DR, Sole M J, Wigle ED (1976) The echocardiographic diagnosis of amyloid cardiomyopathy. Circulation 54, Suppl 11:84Google Scholar
  396. Redwood DR, Schwerer JL, Epstein SE (1974) Biventricular cineangiography in the evaluation of patients with asymmetric septal hypertrophy. Circulation 49:1116PubMedGoogle Scholar
  397. Rees A, Elbl F, Minhas K, Solinger R (1976) Echocardiographic evidence of outflow tract obstruction in Pompe’s disease (glycogen storage disease of the heart). Amer J Cardiol 37:1103PubMedCrossRefGoogle Scholar
  398. Reindell H, Schildge E, Klepzig H, Kirchhoff HW (1955) Kreislaufregulation. Thieme, StuttgartGoogle Scholar
  399. Reindell H, Görnandt L, Bubenheimer P, Dickhuth HH (1988) Kardiomyopathien. In: Reindel H, Budenheimer P, Dickhuth HH, Görnandt L (eds) Funktionsdiagnostik des gesunden und kranken Herzens, S 230. Thieme, StuttgartGoogle Scholar
  400. Roberts WC, Ferrans VJ (1975) Pathologie anatomy of the cardiomyopathies. Hum Path 6:287PubMedCrossRefGoogle Scholar
  401. Roeske WR, O’Rourke RA, Klein A, Leopold G, Karliner JS (1976) Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation 53:286PubMedGoogle Scholar
  402. Rosenbaum MN (1964) Chagasic myocardiopathy. Progr cardiovasc Dis 7:199CrossRefGoogle Scholar
  403. Rosenblum R, Deiman AJ (1965) Valsalva’s maneuver and the systolic murmur of hypertrophic subaortic stenosis: A bedside diagnostic test. Amer J Cardiol 15:868PubMedCrossRefGoogle Scholar
  404. Rosing DR, Kent KM, Borer JS, Seides SF, Maron BJ, Epstein SE (1979 a) Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: I. Hemodynamic effects. Circulation 60:1201PubMedGoogle Scholar
  405. Rosing DR, Kent KM, Maron BJ, Epstein SE (1979 b) Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: II. Effects on exercise capacity and symptomatic status. Circulation 60:1208PubMedGoogle Scholar
  406. Rosing DR, Condit JR, Maron BJ, Kent KM, Leon MB, Bonow RO, Lipson LC, Epstein SE (1981) Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Amer J Cardiol 48:545PubMedCrossRefGoogle Scholar
  407. Roskamm H, Blümchen G, Fiebig H, Schnellbacher K, Wink K, Papst K, Schollmeyer P, Lösel E, Weidemann H, Reindell H (1972) Hämodynamik und Kontraktilitätsreserve bei Myokardiopathien. Dtsch med Wschr 44:1681CrossRefGoogle Scholar
  408. Ross jr J, Braunwald E, Gault JH et al (1966) The mechanism of the interventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation 34:558PubMedGoogle Scholar
  409. Rossen RM, Goodman DJ, Ingham RE, Popp RL (1974) Ventricular systolic septal thickening and excursion in idiopathic hypertrophic subaortic stenosis. New Eng J Med 291:1317PubMedCrossRefGoogle Scholar
  410. Rossen RM, Goodman DJ, Ingham RE, Popp RL (1974) Echocardiographic criteria in the diagnosis of idiopathic hypertrophic subaortic stenosis. Circulation 50:747PubMedGoogle Scholar
  411. Rothlin M, Turina J, Krayenbühl HP, Senning A (1975) Spätresultate nach Operation bei hypertropher obstruktiver Kardiomyopathie. Z Kardiol Suppl 2:20Google Scholar
  412. Rothlin M, Arbenz U, Krayenbühl HP, Turina J, Senning A (1976) Spätresultate nach Operationen bei muskulärer subvalvulärer Aortenstenose. Z Kardiol 65:501PubMedGoogle Scholar
  413. Rubin KA, Morrison J, Padnick MB et al (1979) Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imaging. Amer J Cardiol 44:1040PubMedCrossRefGoogle Scholar
  414. Rudolph W, Bernsmeier A (1962) Klinische und hämodynamische Befunde bei Myokarditis mit ausgeprägter Myokardfibrose und ihre Abgrenzung von der Pericarditis constrictiva. Z Kreisl-Forsch 51:52Google Scholar
  415. Ruebsamen M, Wessel G (1970) Das Loefgren-Syndrom. Med Klin 65:1577Google Scholar
  416. Rupprath G, Voigt J, Koncz S (1982) Differentialdiagnose entzündlicher Herzerkrankungen durch zweidimensionale Echokardiographie. Monatsschr Kinderheilkd 130:498PubMedGoogle Scholar
  417. Sainani GS, Krompotic E, Slodki SJ (1968) Adult heart disease due to the Coxsackie Virus-B-Infection. Medicine (Baltimore) 47:133CrossRefGoogle Scholar
  418. Sanders V (1963) Idiopathic disease of myocardium. A prospective study. Arch intern Med 112:661PubMedGoogle Scholar
  419. Sanders V (1968) The role of “altered antigen” in the production of myocarditis. Circulation Suppl 38 VI: 170Google Scholar
  420. Sanders V, Favour CB (1962) Myocarditis: Infectious and immunologic aspects. Med Ann (DC) 31:310Google Scholar
  421. Sanderson JE, Traill TA, St John Sutton MG et al (1978) Left ventricular relaxation and filling in hypertrophic cardiomyopathy: An echocardiographic study. Brit Heart H 40:596CrossRefGoogle Scholar
  422. Saphir O (1959) Myokarditis. Amer Heart J 57:639PubMedCrossRefGoogle Scholar
  423. Savage DD, Seides SF, Maron BJ, Myers DJ, Epstein SE (1979) Prevalence of arrhythmias during 24-hours electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 59:866PubMedGoogle Scholar
  424. Savage DD, Drayer JIM, Henry WL, Matthews EC, Ware JH, Gardin JM, Cohen ER, Epstein SE, Laraugh JH (1970) Echocardiographic assessment of cardiac function in hypertensive subjects. Circulation 59:623Google Scholar
  425. Scheuer J (1970) Metabolism of the heart in heart failure: Progr cardiovasc Dis 13:24CrossRefGoogle Scholar
  426. Schmaltz AA, Seitz KH, Schenck W, Both A, Kraus B (1986) Restriktive Kardiomyopathie als Spätfolge einer Influenza-A2-Virus-Myokarditis. Z Kardiol 75:605PubMedGoogle Scholar
  427. Schmidt E, Bender F, Bachour G, Gradaus D (1975) Provokationstests in der Diagnostik der idiopathisch hypertrophen Subaortenstenose. Z Kardiol Suppl 2:29Google Scholar
  428. Schneider JF, Emerson TH, Kreger BE, McNamara PM, Kännel WB (1978) Newly acquired left bundle branch block: The Framingham study. Ann intern Med 90:303Google Scholar
  429. Schneider KW, Jesse R, Deeg P, Olsen EGJ, Romen W (1975) Differentialdiagnose der Kardiomyopathien durch die endo-myokardiale Katheterbiopsie. Z Kardiol Suppl 2:24Google Scholar
  430. Schölmerich P (1960) Myokarditis und weitere Myokardiopathien. In: Handbuch Inn Med Bd IX/II, S 869. Springer, Berlin Göttingen HeidelbergGoogle Scholar
  431. Schölmerich P (1967) Pathogenese und Klinik der Myokarditis. Ärztl Prax 19:1111Google Scholar
  432. Schölmerich P (1971) Klinik der Myokarditis. Verh dtsch Ges inn Med 77:335PubMedGoogle Scholar
  433. Schölmerich P (1975) Diagnostik und Verlauf der Virusmyokarditis. Internist 16:508PubMedGoogle Scholar
  434. Schoenfeld MH, Supple EW, Dec GW et al (1987) Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoractomy. Circ 75:1012CrossRefGoogle Scholar
  435. Schowengerdt KO, Towbin JA (1995) Genetic basis of inherited cardiomyopathies. Current Opinion in Cardiology 10:312PubMedCrossRefGoogle Scholar
  436. Schulte HD, Bircks W, Körfer R, Kuhn H (1981) Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM). Thorac cardiovasc Surg 29:375PubMedCrossRefGoogle Scholar
  437. Schultheiss HP, Strauer BE (1992) Behandlung der entzündlichen Herzkrankheit. Arzneimitteltherapie 10:170Google Scholar
  438. Schweizer P, Hanrath P, Bleifeld W, Effert S (1975) Echokardio-graphische Reihenuntersuchungen zur Frage der familiären Häufigkeit der asymmetrischen Septumhypertrophie. Z Kardiol Suppl 2:13Google Scholar
  439. Scovil JA, Nanda NC, Gross CM, Lombardi AC, Gramiak R, Lipchik EO, Manning JA (1976) Echocardiographic studies of abnormalities associated with coarctation of the aorta. Circulation 53:953PubMedGoogle Scholar
  440. Segal J, Harvey P, Gurel T (1965) Diagnosis and treatment of primary myocardial disease. Circulation 32:837PubMedGoogle Scholar
  441. Senn M, Hess OM, Krayenbühl HP (1984) Hypertrophe Kardiomyopathie und Lentiginose. Schweiz med Wschr 114:838PubMedGoogle Scholar
  442. Senning Å (1976) Transventricular relief of idiopathic hypertrophic subaortic stenoses. J cardiovasc Surg 17:371Google Scholar
  443. Senning A, Rothlin M (1982) Chirurgie bei hypertropher obstruktiver Kardiomyopathie. Z Kardiol 71:806PubMedGoogle Scholar
  444. Shah PM, Gramiak R, Kramer DH (1969) Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40:3PubMedGoogle Scholar
  445. Shah PM, Gramiak R, Adelman AG, Wigle ED (1971) Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation 44:891PubMedGoogle Scholar
  446. Shah PM, Gramiak R, Adelmann AG, Wigle ED (1972) Echocardiographic assessment of the effects of outflow obstruction in hypertrophic subaortic stenosis. Circulation 45:516PubMedGoogle Scholar
  447. Shah PM, Adelman AG, Wigle EF, Gobel FL, Brucheil HB, Hardarson T, Curiel R, Caldaza C, Oakley CM, Goodwin JF (1974) The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circulat Res 35/36 (Suppl 2):179Google Scholar
  448. Shah PM (1988) Echocardiography in congestive or dilated cardiomyopathy. J Am Soc Echo 1:20Google Scholar
  449. Simon AL, Ross J, Gault JH (1967) Angiographic anatomy of the left ventricle and mitral valve in idiopathic subaortic stenosis. Circulation 36:852PubMedGoogle Scholar
  450. Smith MR, Agruss NS, Levenson NI, Adolph RJ (1975) Nonobstructive hypertrophic cardiomyopathy mimicking mitral stenosis. Amer J Cardiol 35:89PubMedCrossRefGoogle Scholar
  451. Smith WG (1970) Coxsackie B myocarditis in adults. Amer Heart J 80:34PubMedCrossRefGoogle Scholar
  452. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685CrossRefGoogle Scholar
  453. Somerville J, Bonham-Carter RE (1972) The heart in lentiginosis. Brit Heart J 34:58PubMedCrossRefGoogle Scholar
  454. Sonntag F, Hanrath P, Diemert J, Bleifeld W (1981) Klinische und hämodynamische Befunde in Ruhe und unter Belastung bei Patienten mit hypertropher Kardiomyopathie vor und nach hochdosierter Langzeitbehandlung mit Verapamil. Z Kardiol 70:627Google Scholar
  455. Spencer WH III, Thornsberry C, Moody MD (1970) Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms. Ann intern Med 58:683Google Scholar
  456. Spiller P, Brenner K, Kreuzer H, Neuhaus KL, Niessen HW (1975) Systolische Ventrikel- und Myokardfunktion bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol Suppl 2:8Google Scholar
  457. Staemmler M (1962) Die isolierte (Fiedlersche) Myokarditis. Veröff Pathol 65. Fischer, StuttgartGoogle Scholar
  458. Stapleton JF, Segal JP, Harvey WP (1970) The electrocardiogram of myocardiopathy. Progr cardiovasc Dis 13:217CrossRefGoogle Scholar
  459. Stapleton JF, Segal JP, Harvey WP (1974) Clinical pathway of cardiopathies. Res 34/35 (Suppl 2):168Google Scholar
  460. Stenson RE, Flamm jr MD, Harrison DC et al (1973) Hypertrophic subaortic stenosis: Clinical and hemodynamic effects of long-term propranolol therapy. Amer J Cardiol 31:763PubMedCrossRefGoogle Scholar
  461. Stevenson WG (1995) Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol 10:274PubMedCrossRefGoogle Scholar
  462. St John Sutton MG, Tajik AJ, Gibson DG, Brown DJ, Seward JB, Giuliani ER (1978) Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation 57:512Google Scholar
  463. St John Sutton MG, Tajik AJ, Smith HC et al (1980) Angina in idiopathic hypertrophic subaortic stenosis: A clinical correlate of regional left ventricular dysfunction: a videometric and echocardiographic study. Circulation 61:561Google Scholar
  464. St John Sutton MG, Olukotun AY, Tajik AJ et al (1980) Left ventricular function in Friedreich’s ataxia: An echocardiographic study. Brit Heart J 44:309CrossRefGoogle Scholar
  465. St John Sutton MG, Tajik AJ, Guiliani ER et al (1981) Hypertrophic obstructive cardiomyopathy and lentiginosis: A little known neural ectodermal syndrome. Amer J Cardiol 47:214CrossRefGoogle Scholar
  466. St John Sutton MG, Lie JT, Tajik AJ, Danielson GK, Frye RL (1985) Hypertrophic obstructive cardiomyopathy. Heart Failure 1:4Google Scholar
  467. Storstein O (1964) Primary myocardial disease. Acta med scand 176:731PubMedCrossRefGoogle Scholar
  468. Storstein O (1975) Hemodynamic studies in primary myocardial disease. Acta med scand Suppl 113:472Google Scholar
  469. Strauer BE (1975) Die hypertrophische obstruktive Kardiomyopathie. Internist 16:530PubMedGoogle Scholar
  470. Strauer BE, Bolte H, Heimburg P, Riecker G (1975) Zur koronaren Herzkrankheit II: Eine Analyse diastolischer Druck-Volumen-Beziehungen und linksventrikulärer Dehnbarkeit an 110 Patienten. Z Kardiol 64:311PubMedGoogle Scholar
  471. Strauer BE, Kramer H, Avenhaus H, Bolte H, Lüderitz B, Neubaur J, Riecker G (1975) Hämodynamik, Volumina und Dehnbarkeit des linken Ventrikels bei 167 Patienten mit angeborenen und erworbenen Herzfehlern. Klin Wschr 53:961PubMedCrossRefGoogle Scholar
  472. Strunk BL, Guss SB, Hicks RE, Kotler MN (1975) Echocar-diographic recognition of the mitral valve posterior aortic wall relationship. Circulation 51:594PubMedGoogle Scholar
  473. Sunil K, Dodson D, Dodson VN (1969) Immunglobulin binding in cardiomyopathic heart. Circulation Suppl 39/111:66Google Scholar
  474. Sutton GC, Demakis JA, Anderson TO, Morrissey RA (1971) Serologie evidence of a sporadie outbreak and Illinois of infection by chlamydia (psittacosis-Lgv agent) in patients with primary myocardial disease and respiratory disease. Amer Heart J 81:597PubMedCrossRefGoogle Scholar
  475. Suzuki J, Watanabe F, Takenaka K et al (1993) New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T-waves. J Am Coll Cardiol 22:1175PubMedCrossRefGoogle Scholar
  476. Swan DA, Bell B, Oakley CM et al (1971) Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Brit Heart J 33:671PubMedCrossRefGoogle Scholar
  477. Tajik AJ, Giuliani ER, Weidman WH et al (1974) Idiopathic hypertrophic subaortic stenosis: Long-term surgical follow-up. Amer J Cardiol 34:815PubMedCrossRefGoogle Scholar
  478. Takatsu T (1978) Idiopathic cardiomyopathy. Jpn J Med 17:157CrossRefGoogle Scholar
  479. Tauchert N, Behrenbeck DW, Hötzel J, Hombach V, Jansen W, Niehus B, Obst HP, Hilger HH (1978) Funktioneller Nachweis der “small vessel disease”. Verh dtsch Ges Kreisl-Forsch 172Google Scholar
  480. Teare RD (1958) Asymmetrical hypertrophy of the heart in young adults. Brit Heart J 20:1PubMedCrossRefGoogle Scholar
  481. Thaulow E, Eriksson J, Nitter-Hauge S, Rootwelt K (1980) “False positive exercise test” — a sign of cardiomyopathy? Europ Congr Cardiol (abstract-book 127)Google Scholar
  482. Tracy S, Hufnagel G, Chapman N (1992) Interesting problems in enteroviral inflammatory heart disease. Heart 17:79Google Scholar
  483. Traill TA, Gibson DG, Brown DJ (1978) Study of left ventricular wall thickness and dimension changes using echocardiography. Brit Heart J 40:162PubMedCrossRefGoogle Scholar
  484. Trieb G, Sigwart H, Mannebach H, Gleichmann U (1979) Segmentale frühzeitige Relaxation (SERP) des linken Ventrikels in Ruhe vs. ischämieinduzierter Hypokinesie im Belastungs-angiogramm — eine Korrelationsstudie. Z Kardiol 68:520PubMedGoogle Scholar
  485. Vecht RJ, Oakley CM (1968) Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Brit med J 2:455PubMedCrossRefGoogle Scholar
  486. Waagstein F, Hjalarmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in con-gestivew cardiomyopathy. Br Heart J 37:1022PubMedCrossRefGoogle Scholar
  487. Waagstein F (1995) The role of -blockers in dilated cardiomyopathy. Current Opinion in Cardiology 10:322PubMedCrossRefGoogle Scholar
  488. Watt A (1981) Hypertrophic cardiomyopathy: a disease of impaired adenosine mediated autoregulation of the heart. Lancet 1:127Google Scholar
  489. Weiss MB, Ellis K, Sciacca RR et al (1964) Myocardial blood flow in congestive and hypertrophic cardiomyopathy: Relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 54:484Google Scholar
  490. Wenger R (1964) Endokardfibrosen. Thieme, StuttgartGoogle Scholar
  491. Wenger R (1971) Endomyokardfibrosen. Verh dtsch Ges inn Med 77:65PubMedGoogle Scholar
  492. Whalen RE, Cohen AI, Summer RG et al (1963) Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis. Amer J Cardiol 11:8PubMedCrossRefGoogle Scholar
  493. Whiting RB, Powell jr WJ, Dinsmore RE et al (1971) Idiopathic hypertrophic subaortic stenosis in the elderly. N Engl J Med 96:326Google Scholar
  494. WHO (1980): Report of the WHO-ISFC task force on the definition and classification of cardiomyopathies. Brit Heart J 44:672CrossRefGoogle Scholar
  495. WHO Expert Committee (1984) Cardiomyopathies. WHO Tech Rep Ser 697Google Scholar
  496. Wigle ED (1964) Muscular subaortic stenosis: The clinical syndrome, with additional evidence of ventricular septal hypertrophy. In: Wolstenholme GEW, O’Conner M (eds) Ciba Foundation Symposium on Cardiomyopathies, S 49. Churchill Livingstone, LondonCrossRefGoogle Scholar
  497. Wigle ED, Silver MD (1978) Myocardial fiber disarray and ventricular septal hypertrophy in asymmetrical hypertrophy of the heart. Circulation 58:398PubMedGoogle Scholar
  498. Wigle ED, Felderhof CH, Silver MD, Adelman AG (1973) Hypertrophic obstructive cardiomyopathy. In: Fowler ED (ed) Myocardial diseases, S 297. Grune&Stratton, New YorkGoogle Scholar
  499. Wigle ED, Adelman AG, Felderhof CH (1974) Medical and surgical treatment of the cardiomyopathies. Circulat Res 34/35 (Suppl 2): 196Google Scholar
  500. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG (1985) Hypertrophic cardiomyopathy, the importance of the site and the extent of hypertrophy. A review. Prog cardiovasc Dis 28:1PubMedCrossRefGoogle Scholar
  501. Wigle ED (1995) Novel insights into the clinical manifestations and treatment of hypertrophic cardiomyopathy. Curr Opin Cardiol 10:299PubMedCrossRefGoogle Scholar
  502. Wilansky S, Pollick C (1989) Acute myocarditis presenting as asymmetric septal hypertrophy. Can J Cardiol 5:75PubMedGoogle Scholar
  503. Williams WG, Wigle ED, Rakowski H et al (1987) Results of surgery for idiopathic hypertrophic obstructive cardiomyopathy. Circulation 76 (Suppl 5):V–104Google Scholar
  504. Wilson FM, Miranda QR, Chason JL, Lerner AM (1969) Residual pathologic changes following murine Coxsackie A and B myocarditis. Amer J Path 55:253PubMedGoogle Scholar
  505. Windorfer A (1966) Die akute Virus-Myokarditis beim Kind. Münch med Wschr 108:2213PubMedGoogle Scholar
  506. Wink K, Hagemann G, Brett W, Barmeyer J, Reindell H (1975) Verlaufsbeobachtungen bei verschiedenen Formen der Kardiomyopathien. Z Kardiol Suppl 2:18Google Scholar
  507. Witzke DJ, Kay MP (1976) Hypertrophie cardiomyopathy induced by administration of nerve growth factor (abstract). Circulation 54 (suppl 2):88Google Scholar
  508. Woodward TE, McCrumb jr FR, Carey TN, Togo Y (1960) Viral and rickettsial causes of cardiac disease, including the Coxsackie virus etiology of pericarditis and myocarditis. Ann intern Med 53:1130PubMedGoogle Scholar
  509. Yamaguchi H, Ischimura T, Nishiyama S, Nagasaki F, Nakanishi T, Takatsu F, Nishija T, Umeda T, Machii K (1979) Hypertrophic non obstructive cardiomyopathy with giant negative T-waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Amer J Cardiol 44:401PubMedCrossRefGoogle Scholar
  510. Yu PN, Schreiner BF, Cohen J, Murphy GW (1966) Idiopathic cardiomyopathy. A study of left ventricular function and pulmonary circulation in 15 patients. Amer Heart J 71:330PubMedCrossRefGoogle Scholar
  511. Zebe H, Mall G (1979) Die Myokarditis. Dtsch Ärztebl 33:2089Google Scholar
  512. Zöllner N, Lydtin H (1967) Über ein gehäuftes Auftreten pathologischer Herzbefunde bei Coxsackie-Infektionen Erwachsener. Dtsch med Wschr 92:2049PubMedCrossRefGoogle Scholar
  513. Alexander CS, Nino A (1969) Cardiovascular complications in young patients taking psychotherapeutic drugs. Amer Heart J 78:757PubMedCrossRefGoogle Scholar
  514. Alexander J, Dainiak N, Berger HJ, Goldmann L, Johnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL (1979) Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. New Engl J Med 300:278PubMedCrossRefGoogle Scholar
  515. Appelbaum F, Sträuchen JA, Graw jr RG (1976) Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1:58PubMedCrossRefGoogle Scholar
  516. Arsenian MA (1991) Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis 33:299PubMedCrossRefGoogle Scholar
  517. Arzneimittelkommission der Deutschen Ärzteschaft (1994) Sumatriptan-haltige Arzneimittel. Bundesgesundheitsamt: Abwehr von Arzneimittelrisiken, Stufe II. Dtsch Ärztebl 91:B-1367Google Scholar
  518. Bana DX, MacNeal PS, LeCompte PM, Shah Y, Graham JR (1974) Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. Am Heart J 88:640PubMedCrossRefGoogle Scholar
  519. Berg A, Baumstark MW, Frey I, Halle M, Keul J (1991) Clinical and therapeutic use of probucol. Eur J Clin Pharmacol 40 (Suppl 1):S 81CrossRefGoogle Scholar
  520. Bilheimer DW (1989) Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis (Suppl I):I-158Google Scholar
  521. Billmann GF (1990) Mechanisms responsible for the cardiotoxic effects of cocaine. FASEB J 4:2469–2475Google Scholar
  522. Blanc F, Siguier F (1950) L’amibiase: étude clinique et thérapeutique. I. L’expansion scientifique françaiseGoogle Scholar
  523. Bloom KR, Bini RM, Williams CM, Sonley MJ, Gribbin MA (1978) Echocardiography in adriamycin cardiotoxicity. Cancer 41:1265PubMedCrossRefGoogle Scholar
  524. Blum RH, Carter SK (1974) Adriamycin: A new anti-cancer drug with significant clinical activity. Ann inter Med 80:249Google Scholar
  525. Bouvrain Y, Roujeau J, Rogard JM (1977) Myocardite post-radiothérapeutique. Sem Hop Paris 53:433PubMedGoogle Scholar
  526. Brem TH, Konwaller BE (1955) Fetal myocarditis due to emetine hydrochloride. Amer Heart J 50:477CrossRefGoogle Scholar
  527. Burch GE, Sohal RS, Sun JC, Miller JC, Colcolough HL (1968) Effects of radiation on the human heart. An electron microscopic study. Arch intern Med 121:230PubMedCrossRefGoogle Scholar
  528. Carlson RG, Mayfield WR, Normann S, Alexander JA (1991) Radiation-associated valvular disease. Chest 99:538PubMedCrossRefGoogle Scholar
  529. Catterai M, Evans W (1960) Myocardial injury from thérapeutique irradiation. Brit Heart J 22:168CrossRefGoogle Scholar
  530. Cohen MC, Huberman MS, Nesto RW (1988) Recombinant al-pha-2 interferon related cardiomyopathy. Am J Med 85:549PubMedCrossRefGoogle Scholar
  531. Cohnen G (1976) Arzneimittelinduzierte Lupus-erythematodes-ähnliche Syndrome. Med Klin 71:789Google Scholar
  532. Colditz GA, Willett WC, Stampfer MJ et al (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105PubMedCrossRefGoogle Scholar
  533. Demers RG, Heninger GR (1971) Electrocardiographic changes during lithium carbonate treatment. J Amer med Ass 218:381CrossRefGoogle Scholar
  534. Dempsy J J, Salem HH (1966) An enzymatic electrocardiographic study on toxicity of dehydroemetine. Brit Heart J 28:505CrossRefGoogle Scholar
  535. Desautels S, Filteau C, St Jean A (1964) Ventricular tachycardia associated with administration of thioridaxine hydrochloride. Canad med Mass J 90:1030Google Scholar
  536. Di Matteo J, Vacheron A, Heulin A, Meeus L, Di Matteo G, Gilles R, Delage F, De Ratuld A (1978) Complications cardiaques de la radiothérapie thoracique. Arch Mal Couer 71:447Google Scholar
  537. Dollinger MR, Lavine DM, Foye LV (1966) Myocardial infarction due to post-irradiation fibrosis of the coronary arteries. J Amer med Ass 195:316CrossRefGoogle Scholar
  538. Fahraeus L, Wallentin L (1983) High density lipoprotein sub-fractions during oral and cutaneous administration of beta-estradiol to menopausal women. J Clin Endocrinol Metab 56:797PubMedCrossRefGoogle Scholar
  539. Fajardo LF, Stewart JR (1970) Experimental radiation-induced heart disease. Amer J Pathol 59:299Google Scholar
  540. Fajardo LF, Stewart JR (1973) Pathogenesis of radiation induced myocardial fibrosis. Lab Invest 29:244PubMedGoogle Scholar
  541. Fänger H, Lushbaugh CC (1967) Radiation death from cardiovascular shock following accident. Arch Pathol 83:446PubMedGoogle Scholar
  542. Fowler NO, McCall D, Chou T (1976) Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Amer J Cardiol 37:223PubMedCrossRefGoogle Scholar
  543. Giard P, Crinquette J (1970) Cardiomyopathie radiothérapique: mécanisme pathogénique par autoanticorps. Sem Hôp, Paris 46:923Google Scholar
  544. Giardina EGV, Johnson LL, Vita J, Bigger JT Jr, Brem RF (1985) Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arryhthmias. Am Hear J 109:992CrossRefGoogle Scholar
  545. Granfone A, Campos H, McNamara JR et al (1992) Effects of estrogen replacement on plasma lipoproteins and apolipo-proteins in postmenopausal, dyslipidemic women. Metabolism 41:1193PubMedCrossRefGoogle Scholar
  546. Greenwood RD, Rosenthal A, Cassady R, Jaffee N, Nadas AS (1974) Constrictive pericarditis in childhood due to mediastinal irradiation. Circulation 50:1033PubMedGoogle Scholar
  547. Guérin RA, Chenal C, Dali Youcef F (1977) Conditions cliniques et techniques d’apparition des complications en-dothoraciques des irritations externes. Rev fr Mal resp 5:283Google Scholar
  548. Haiat R, Uzan C, Chiche P (1977) Action cardiovasculaire du lithium. Coeur Med int 6:251Google Scholar
  549. Halazoun JF, Wagner HR, Geata JF (1974) Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. Cancer 33:545CrossRefGoogle Scholar
  550. Harrison ET, Sanders LA (1976) Pericarditis in a early case of daunorubicin cardiomyopathy. Ann intern Med 85:339PubMedGoogle Scholar
  551. Honey M (1960) The effects of sodium antimony tartrate on the myocardium. Brit Heart J 22:601PubMedCrossRefGoogle Scholar
  552. Jefferson JW (1975) A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom Med 37:160PubMedGoogle Scholar
  553. Jeffrey RW, Wing RR, French SA (1992) Weight cycling and cardiovascular risk factors in obese men and women. Am J Clin Nutr 55:641Google Scholar
  554. Kane JP, Mallory MJ, Ports IA, Phillips NR, Diehl JC, Havel RJ (1990) Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. J Am Med Ass 264:3007CrossRefGoogle Scholar
  555. Keelan Jr MH, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch intern Med 134:145PubMedCrossRefGoogle Scholar
  556. Kessler KM, Cox M, De Marchena E J, Myerburg RJ (1989) Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline. Am Heart J 117:964PubMedCrossRefGoogle Scholar
  557. Klein LS, Simpson RJ Jr, Stern R, Hayward JC, Foster JR (1982) Myocardial infarction following administration of sublingual ergotamine. Chest 82:375PubMedCrossRefGoogle Scholar
  558. Kloner RA, Hale S, Alker K, Rezkalla S (1992) The effects of acute and chronic cocaine use on the heart. Circulation 85:407PubMedGoogle Scholar
  559. Lange RA, Cigarroa RG, Yancy CW et al (1989) Cocaine-induced coronary artery vasoconstriction. N Engl J Med 321:1557PubMedCrossRefGoogle Scholar
  560. Leaf A, Weber PC (1988) Cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549PubMedCrossRefGoogle Scholar
  561. Lefrak EA, Pitha J, Rosenheims S et al (1975) Adriamycin (NCS-123127) cardiomyopathy. Cancer Chemother Rep 6:195Google Scholar
  562. Lenarz L, Page JA (1976) Cardiotoxicity of Adriamycin and related anthracyclines. Cancer Treat Rev 3:111CrossRefGoogle Scholar
  563. Levine DG, Marshall A J (1975) Cardiac arrhythmias induced by phenothiazine. Lancet 11:990Google Scholar
  564. Lindsay S, Kohn H J, Dakin RL, Jew J (1962) Aortic arteriosclerosis in the dog after localized aortic x-radiation. Circulât Res 10:51PubMedGoogle Scholar
  565. Lipworth BJ, McDevitt DG, Struthers AD (1990) Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Chest 98:811PubMedCrossRefGoogle Scholar
  566. May D, Wandl U, Becher R et al (1990) Kardiale Nebenwirkungen von 5-Fluorouracil. Dtsch Med Wsch 115:110Google Scholar
  567. McReynolds RA, Gold DL, Roberts WC (1976) Coronary heart disease after mediastinal irradiation for Hodgkin’s disease. Amer J Med 60:39PubMedCrossRefGoogle Scholar
  568. Michael TAD, Arivazzadek S (1970) The effects of acute chloroquine poisoning with special reference to the heart. Amer Heart J 70:831CrossRefGoogle Scholar
  569. Mikhail JR et al (1975) Abnormal electrocardiographic findings in sarcoidosis. Proc VI ICS Univ Tokyo Press 365Google Scholar
  570. Minow RA, Benjamin RS, Gottlieb JA (1975) Adriamycin (NCS-123127) cardiomyopathy. An overview with determination of risk factors. Cancer Chemother Rep 6:195Google Scholar
  571. Minow RA, Benjamin RS, Lee ET, Gottlieb JA (1977) Adriamycin cardiomyopathy-risk factors. Cancer 39:1397PubMedCrossRefGoogle Scholar
  572. Morin Y, Cote SK (1972) Toxic agents and cardiomyopathies. Cardiovasc Clin 4:245PubMedGoogle Scholar
  573. Morton DL, Glancy DL, Joseph WL, Adkins PL (1973) Management of patients with radiation induced pericarditis with effusion. Chest 64:291PubMedCrossRefGoogle Scholar
  574. Motté G, Waynberger M, Bailly J et al (1970) Myocarditis émé-tienne. A propos d’un cas mortel dû à la 2-dehydroémétine. Ann Med int (Paris) 12:979Google Scholar
  575. Murphy ML, Bullock RT, Pearce MB (1974) The correlation of metabolic and ultrastructural changes in emetine myocardial toxicity. Amer Heart J 87:105PubMedCrossRefGoogle Scholar
  576. Ni Y, von Segesser JK, Turina M (1990) Futility of pericardiecto-my for postirradiation constrictive pericarditis. Ann Thorac Surg 49:445PubMedCrossRefGoogle Scholar
  577. O’Connel TX, Berenbaum MD (1974) Cardiac and pulmonary effects of high doses of cyclophosphamide and isophospha-mide. Cancer Res 34:1586Google Scholar
  578. Ornish D, Brown SE, Schweritz LW et al (1990) Can lifestyle changes reverse coronary heart disease: The Lifestyle Heart Trial. Lancet 336:129PubMedCrossRefGoogle Scholar
  579. Pearce MB, Bullock RT, Murphy ML (1971) Selective damage of mitochondria due to emetine hydrochloride. Arch Pathol 91:8PubMedGoogle Scholar
  580. Prentice R (1965) Myocardial infarction following radiation. Lancet 11:388CrossRefGoogle Scholar
  581. Prior JG, Cochrane GM (1981) Self-poisoning with oral salbutamol. Br Med J 282:1932CrossRefGoogle Scholar
  582. Raisfeld IH (1972) Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Amer Heart J 83:129PubMedCrossRefGoogle Scholar
  583. Richardson HL, Graupner HE, Richardson ME (1966) Intramyocardial lesions in patients dying suddenly and unexpectedly. J Amer med Ass 195:254CrossRefGoogle Scholar
  584. Rinehart J J, Lewis RP, Balcerzak SP (1974) Adriamycin cardiotoxicity in man. Ann intern Med 81:475PubMedGoogle Scholar
  585. Roberts WC, Ferrans VJ (1975) Pathologic anatomy of the cardiomyopathies. Hum Path 6:287PubMedCrossRefGoogle Scholar
  586. Robinson DS, Barker E (1976) Tricyclic antidepressant cardiotoxicity. J Amer med Ass 236:2089CrossRefGoogle Scholar
  587. Rosenberg SA, Lotze MT, Muul LM et al (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316:889PubMedCrossRefGoogle Scholar
  588. Saint-Pierre A, Perrin A, Pouzerate JP, Favrot B (1972) Myocardiopathie chronique induite par l’imipramine. Coeur Med int 11:27Google Scholar
  589. Sanghri LM, Mathur BB (1965) Electrocardiogram after chloroquine and emetine. Circulation 32:281Google Scholar
  590. Schell FC, Yap H-Y, Blumenschein G, Valvdivieso M, Bodey G (1982) Potential cardiotoxicity with mitoxantrone. Cancer Treat Rep 66:1641PubMedGoogle Scholar
  591. Schwartz JA (1977) Medikamentös induzierte Lupus-erythema-todesähnliche Erkrankungen. Arzneim-Forsch 27:1856Google Scholar
  592. Schwartz RG, McKenzie WB, Alexander J et al: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy, seven-year experience using serial radionuclide angiocardiography. Am J Med 82:1109Google Scholar
  593. Seneff M, Scott J, Friedman B, Smith M (1990) Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability. Ann Emerg Med 19:671PubMedCrossRefGoogle Scholar
  594. Silevski-Iliskovic N, Kaul N, Singal PK (1994) Probucol promotes endogenous antioxydants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89:2829Google Scholar
  595. Stewart JR, Cohn KE, Fajardo LF, Hancock EN, Kaplan HS (1967) Radiation induced heart disease. Radiology 89:302Google Scholar
  596. Sullivan JM, Van der Zwaag R, Hughes JP (1990) Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women. Arch Intern Med 150:2557PubMedCrossRefGoogle Scholar
  597. Thompson GR, Barbir M, Okabayashi K, Trayner I, Larkin S (1989) Plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 9 (Suppl I):I-152Google Scholar
  598. Tilkian A, Schroeder JS, Kao J, Hultgren H (1976) Effect of lithium on cardiovascular performance: Report on extended ambulatory monitoring and exercise testing before and during lithium therapy. Amer J Cardiol 38:701PubMedCrossRefGoogle Scholar
  599. Tseng HC (1971) Interstitial myocarditis probably related to lithium carbonate intoxication. Arch Pathol 92Google Scholar
  600. Tzivoni D, Ratzrowski E, Biran S, Brook JG, Stern S (1977) Complete heart block following therapeutic irradiation at the left side of the chest. Chest 71:231PubMedCrossRefGoogle Scholar
  601. Von Hoff DD, Layard MW, Basa P, Davis jr HL, von Hoff AL, Rosenzweig M, Muggia FM (1979) Risk factors for dox-orubicin-induced congestive heart failure. Ann intern Med 91:710Google Scholar
  602. Weinstein P, Greenwald ES, Grossmann J (1976) Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin’s disease. Amer J Med 60:38CrossRefGoogle Scholar
  603. Weiss RB, Grillo-Lopez AJ, Marsoni S et al (1986) Amsacrine-associated cardiotoxicity: An analysis of 82 cases. J Chir One 105:67Google Scholar
  604. Wellens HJ, Cats VM, Düren DR (1975) Symptomatic sinus node abnormalities following lithium carbonate therapy. Amer J Med 59:285PubMedCrossRefGoogle Scholar
  605. Wenzel DG (1967) Drug induced cardiomyopathies. A preliminary report. J pharm Sci 56:1209PubMedCrossRefGoogle Scholar
  606. Wilson JD (1980) Antinuclear antibodies and cardiovascular drugs. Drugs 19:292PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • L. Görnandt
  • P. Bubenheimer
  • H. Reindell
  • A. Weisswange

There are no affiliations available

Personalised recommendations